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SEC'11 ION 1 
INTRODUCTION 
This thesis represents a personal experience in the use of 
allograft heart valve tissue in cardiac surgery gained from clinical 
practice and supplemented by a research investigation designed to 
clarify certain unresolved problems in this field. 
My initial clinical interest in the use of allograft heart 
valves was stimulated during 1970 and 1971 when working in the 
Cardiothoracic Unit of Wentworth Hospital, Durban, where the frame-
mounted human aortic valve was used as an attractive alternative to 
the prosthetic valves then available for the replacement of diseased 
heart valves. 
During 1972 and 1973 a major impetus to my interest was provided 
by a clinical surgical attachment to the National Heart Hospital, 
London. This is a centre well known for pioneering and continuing 
work in the field of homograft valve use. As Senior Surgical 
Registrar to Mr . J. Keith Ross, Mr . Donald Ross and Mr. L. Gonzalez-
Lavin I became thoroughly familiar with the clinical use of homograft 
he<>,rt valves, and from them originates much of the stimulation and 
continued encouragement responsible for this thesis. 
For the past two years I have been engaged in a research project 
designed to clarify problems raised in the establishment of a 
clinical allograft valve practice in Glasgow. Continued. liaison 
during this period with the Homograft Department of the National 
Heart Hospital has ensured the contemporary clinical relevance of 
the research project and has strengthened the important link between 
research work and clinical practice . 
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ASPEcr s O? 'rHESIS IN WHICH WORK HAS BEEN DONE PERSONALLY: 
Every operation in the Animal study (Section 6) has been 
done personally , with the assistance of a vetinary nurse . This 
has included anaesthesia, assessment of pressures and performance 
of angiography and measurement of valves , and post-operative care 
of the animals . 
The obtaining of donor tissue has always been done personally , 
as has been the mixing of Antibiotic- nutrient solutions and care 
of valve tissue during storage . 
'l'h.e majority of the tissue culture work has been done 
personally. Assessment of histol ogical findings has been done 
personally, but in this specialised field I have relied on help 
from others, in particular Professor R. E. B. Hudson , for sub-
sequent checking of con cl us ions. 
All the illustrations for the thesis have been done personally . 
All the clinical investigations for the writing of Section 3c 
and 3d have been done personally. 
'rhe establishment of clinical allograft valve replacement in 
Gl asgow , which provided much of the impetus for this work , was a 
personal undert-aking, and involved me in the obtaining of valve 
tissue , its preparation, and the clinical surgery. 
The opportunities given to me are much appreciated and are 
acknowledged in Section 8 . 
PARTS OF' THESIS IN WHICH WORK HAS BEEN DONE BY OTHERS: 
Assessment of protein and collagen synthesis has been 
performed by Professor J .O. 'D . lfoGee. 
Some .of the tissue culture work has been performed by 
Dr . C. G. A. McGregor for me under my guidance - this was a very 
eJ@..cting aspect of the work and I am grateful to him for his help 
here. 
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PARTS Qlt, THESIS IN WHICH WORK HAS BEEN DONE BY OTHERS: (Cont.) 
The specimens for the Animal Study were cut and mounted 
for me by the Vi ctoria Infirmary Department of Pathology - largely 
by Dr. McGregor . 
Photography has been done by the Photographic Departments 
of the Vetinary School or the Victoria Infirmary. 
Identification of chromosomes has been done for me by 
Dr. Harvey or Dr. Logue of the Animal Reproduction Department at 
the Vetinary School. 
In each case I was familiar with the principles and 
techniques of the i nvestigations, and have acknowledged this help 
in Section 8. 
PUBLICATION OF ASPECTS OF WORK COVERED BY THIS THESIS: 
Section 3d has appeared as a publication - "Reconstruction of 
Ri ght Ventricular Outflow with a Valved Homograft Conduit" by 
D.J. Wheatley , s. Prusty and D. N. Ross - in Thorax , Volume 29 No . 6 , 
page 617, November 1974 . The data included in this part of the 
thesis has also been presented at the Sooiety of T'noracic and 
Cardiovascular Surgeons of Great Britain in Cambridge, in 1973 by 
me . The article has been written by me and has considera-ble 
relevance to this work , and is therefore included. 
Section 5a has been submitted for publication to the 
journal "Cardiovascular Research" under the title 11Tissue Culture, 
Protein and Collagen Synthesis in Antibiotic Sterilised Canine 
Heart Valves" , with authors C. G. A. McGregor , J . F . Bradley, 
J. O'D. McGee and D. J . Wheatley. 
Section 5b , with titl e "Viability in Human Heart Valves 
prepared for Grafting" with the same authors has been submitted 
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PUBLICATION OF ASPECTS OF WORK COVERED BY THIS THESIS (Cont.): 
to the same journal. Both articles have bee n accepted for 
publication and will appear in 1976, probably in March . In view 
of the part played in the study by the other authors, as well as 
the contemporary clinical relevance the work has been submitted 
for publication, but its inclusion in this thesis in mandatory 
in view of the relevance to the animal study. 
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SEC'rION 2 
BACKGROUND 'I'O THESIS 
"FIBROBLAST VIABILITY IN 'l1HE ALLOGRAF'r HEAR'r VALVE LEAB'LET" 
Choice of Heart Valve Substitutes 
The cardiac surgeon continually faces the problem of 
choosing a suitable replacement for diseased heart valves. 
This problem also arises in certain congenital defects requiring 
a valved conduit for r econstruction. 
The ideal valve for this purpose is not yet established. 
I 
This is reflected in the wide variety of alternatives available 
(McGoon, 1971; Karp et al., 1974; LongJnore , 1975 ). 
In spite of considerable ingenuity of design and production 
of prosthetic valves, many d.i'fficulties have been encountered. 
The major problem remains the ever-present hazard of thrombo-
embolism and the need for long-term anticoagulation. Although 
earlier problems of mechanical failure , haemolysis and poor 
haemodynamic function are less frequent, they have not been 
eliminated (Starr , 1975; Bjork, 1975). 
In an attempt to overcome the problems of thrombo-embolism 
various biological tissues have been used for valve construction 
( Puig et al. , 1975 ; Ionescu et al., 1974). The most notable of 
these has been the fascia lata i valve (Senning, 1967). However, 
poor long-term results have marred initial successes ( Ionescu , 1975; 
McEnany et al. 1 197 2 ) , and most of these forms of biological 
valves have been abandoned (Senning, 1975; Parker, 1975 ) . 
The Allograft Heart Valve 
Transplantation of a healthy valve from the same species 
( a "homograft" heart valve, or "allograft " heart valve - the more 
recent ly preferred term for tissue grafted from one individual to 
another of the same species) offers an attractive solution to the 
6 
problem• Allograft (homograft) valves offer op~imal haemodynamic 
characteristics, with freedom from haemolysis and the risk of 
sudden mechanical failure (Ro ss , 1972 and 1975; Yacoub, 1975; 
Angell et al., 1975a). 
The Need for Sterilisation and Preservation 
Although initially small numbers of allograft valves were 
obtained under sterile conditions and not subjected to sterilisation 
or prolonged storage before implantation, this raises practical 
problems. In addition,the sterility of such autopsy material 
is unreliable (Yacoub and Kittle, 1970). Thus, for practical 
rwsons it is necessary to make use of routine autopsy material 
to obtain sufficient suitable valves. This dictates the need for 
a method of valve sterilisation. Also, some form of storage is 
necessary to allow the accumulation of a suitable range of valves 
for clinicaluse. 
Thus, a variety of methods for the sterilisation and 
preservation of allograft valves has been described, most 
commonly involving the use of ethylene-oxide, beta-propiolactone, 
er garn.~a-irradiation for sterilisation, and some form of freezing 
and low-temperature storage for preservation (Lonl§llore et al. , 1966; 
Pickering, 1966; Barnes et al., 1970; Malm et al., 1967). 
Late Failure of Allograft Valves 
From the time of the first use of the allograft valve in 
the sub-coronary position in 1962 (Ross, 1962) a high incidence 
of late valve failure has detracted from otherwise excellent 
clinical results (Ross, 1975; Wallace et al. , 1974). This 
failure has been ascribed to methods used in the past for 
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sterilisation and preservation of the allograft valve 
(Aparicio et al., 1975; Missen and Roberts, 1970; Gavin et al., 
1972; Bolooki et al., 1972; Hoeksema et al., 1967; Ross, 1972 
and 1975; Hudson, 1966; Smith, 1966; Clark, 1973). 
Antibiotic Sterilisation 
Antibiotic sterilisation of allograft valves is now widely 
used, with much improved long-term results (Barratt-Boyes and 
Roche, 1969; Barratt-Boyes et al., 1972; Angell et al., 1973a; 
Ross, 1975; Yacoub, 1975). 
Importance of Viability in Allograft Valves 
It has been suggested that viability of the valve at the 
time of implantation may be an import ant factor influencing long-
term function in allograft valves (Kosek et al., 1969 ; Angell et al ., 
1972). 
Reports of experiment al work in dogs showing survival of 
living donor cells in the leaflets of transplanted allograft heart 
valves (Mohri et al., 1967a, 1967b and 1968 ; Buch et al., 1971: 
Kosek et al., 1969 ; Angell et al., 1973a ) have encouraged 
Gpeculation that living cells in viable valves continue to survive 
after allotransplantation in man. Such living valves would be 
capable of remoulding, repairing and strengthening the impla.n.ted 
valve , thus providing a living, self-repairing permanent replace-
ment (Al-Janabi et al. , 1972 and 1973; Al-Janabi 1 1975; 
Lockey et al. 1 1972; Hammon et al., 1974; Angell et al., 1973a; 
Kosek et al. , 1969 ). 
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haintenance of Viability in Allograft Valves 
Such has been the emphasis on preserving viability in 
allograft valves prepared for clinical use that many antibiotic 
formulae have been recommended which will not impair viability, 
but which , at the same time, will satisfactorily sterilise the 
valve (Angell et al ., 1973b; Lockey et al ., 1972 ; Waterworth 
et al., 1974; Yacoub, 1975) . 
Further, t he addition of a nutrient medium to such formulae 
has been advised, in an attempt to improve preservation of valve 
viability (Al-Janabi , 1972 and 1975 ; Lockey et al. ,. 1972 ). 
Also, storage o~ viable valves at -195°C, using 15% dimethyl 
sulphoxide as a cryoprotective agent, has been used with the aim 
of indefinitely retaining viability in valves for clinical use 
(Al-Janabi 7 1975). 
Tests of Viability 
As a result of this belief in the importance of allograft 
valve viability, several tests , some very elaborate , have been 
advocated for the assessment of valve viability - either demon-
stration of tissue culture growth of l eaflet fibroblasts I or 
d.emonstration of biosynthetic activity in leaflet fibroblasts 
(Angell et al. , 1973 a and 1973b; Al-Janabi et al., 1972 and 1973; 
Al-Janabi , 1975 ; Yacoub, 1975). 
Conflict ing Evidence Regarding Viability 
Not all workers are convinced about the importance of valve 
viability . Notably , the New Zealand group of Barratt-Boyes , which 
in fact pioneered a.Y1tibiotic sterilisation of allograft valves and 
reported improved long-term results , believe that the histological 
changes in fresh allografts are essentially the same as in chemically 
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sterilised valves (Gavin et al. , 1973a) . They believe that donor 
cells do not survive in antibiotic sterilised valves following 
allotransplantation (having disappeared in fact by 40 days ) despite 
evidence of viability at the time of insertion (Gavin et al., 1973b). 
Furthermore , the experimental evidence for continued donor 
cell survival in valves following allotransplantation is conflicting. 
There are reports of rapid loss of leaflet cellularity following 
transplantation of fresh valves in dogs (Beall et al., 1961; 
Duran et al., 1965 ; Duran and IoI'nitehead, 1968) which confl.ict 
with evidence for continued donor cell survival. Even in the 
report s showing post-implantation survival (Mohri et al. , 1968) 
it is apparent that progressive loss of donor cells occurs. It 
is of considerable interest that Mohri' s group compared viable 
valves with non-viable beta-propiolactone sterilised valves, and 
concluded that the non-viable grafts appeared superior to the 
viable up to 121 months because of better maintained leaflet 
pliability. 
Alternatives to Allograft Valves 
The recent ready avail ability of a promising alt erative to 
the allograft valve - the glutaraldehyde preserved heterograft 
valve - (Hancock Laboratories . Incorporated, 1975; Johnson et al. , 
1975; Horowitz et al., 1974; Carpentier et al., 1974; 
Carpentier et al., 1975 ), which appears to offer the same 
advantages as the allograft valve with satisfactory durability 
to date, makes it important to assess carefully the claims made 
for viability in allograft valves. 
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The· Need for Investigation of Fibroblast Viability in the 
Allograft Heart Valve Leaflet 
It is probably true to state that the case for the allograft 
valve in 1975 is based on the asswnption of living cells within the 
valve leaflets surviving after implantation to provide a living 
valve substitute (Reid, 1975). 
In striving to maintain viability of fibroblasts within 
leaflets of allograft valves prior to their implantation con-
siderable problems arise, namely:-
1) The problem arises of attempting to reconcile two 
conflicting aims - the killing of bacteria and fungi on 
the surface of the valves, but not at the same time killing 
the cells within the leaflets of the valve. 'I1his is the 
reason for the large number of antibiotic formulae which 
have been used, and is also the reason that antibiotic 
sterilisation may not be entirely reliable (Lockey, 1975; 
Waterworth et al., 1974). 
2) A degree of urgency is imposed on harvesting of valves, 
with efforts being required to obt ain autopsy material 
with minimal delay after death. 
3) A time limit is imposed on storage periods for clinical 
use ( at present 8 weeks at the National Heart Hospital) , 
but logically an obligation exists to use the valves with 
minimal delay. 
4) The requirement for some form of viability assessment 
arises, to monitor the effect that sterilisation and 
storage procedures are having on allograft _ valve viability. 
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5) There is an ever-present hazard that the temptation to 
reduce exposure to potentially cytotoxic antibiotics to 
a minimum may result in incomplete valve sterilisation, 
with endocarditis in the recipient. The pitfalls of 
bacteriological tests on antibiotic sterilised valves 
have been pointed out by Waterworth et al. (1974) and 
Lockey (1975). 
6) There is the possibility that undue attention to the 
problems of viability may detract attention from other, 
possibly more important factors, such as the physical 
effects on the collagen , elastic tissue or ground 
substance of the valve of various sterilisation and 
storage procedures (Gavin et al., 1973a; Carpeniier _et al., 
1975). As an example of this possibility, it is reported 
that structural integrity is impaired in viable valves 
cool ed to - 195°c with dimethyl sulphoxide (Al-Janabi -
personal communication). 
Clearly, these problems would be largely resolved by 
accurate knowledge of the state of fibroblast viability of heart 
valve leaflets available for grafting, and the effect on that 
viability of antibiotic sterilisation and storage . Even this 
is a source of considerable difference of opinion ( Gavin et al._, 
1973c). 
Also, an investigation into the state of viability following 
implantation of a viable allograft valve is of pressing importance 
in view of the conflicting and uncertain evidence from animal 
experimentation. Because of the present availability of 
acceptable alternatives to the allograft valve - either the 
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glutareldehyde preserved heterograft or the recent improved 
prosthetic valves (Barnhorst et al ., 1975) - the need to 
substantiate or to refute the claims made for continued donor 
fibroblast survival following allograft valve implantation, 
and the modification of such valves by these cells, becomes 
more urgent and important. 
The need for this investigation beca~e apparent during 
early 1974 in the process of establishing clinical .Allograft 
Heart Valve surgery in Glasgow. At this stage the problems 
already referred to, of harvesting, sterilising and prese:"1-ng 
allograft valves were highlighted by personal practical experience. 
In addition,it became clear that with improvements in prosthetic 
valve design, and the appearance of a clinically well-tried 
heterograft valve on the market, the defence of the allograft 
valve became more difficult, and in fact, appeared to depend 
on the alleged survival of donor fibroblasts which could 
favourably modify the implanted valve. 
Thus an Investigation was undertaken - the results of which 
form the basis of Sections 5 and 6 of this Thesis. 
Initially, a study was made of leaflet fibroblast viability 
in fresh canine heart valve~ and the effects of antibiotic 
sterilisation and storage were investigated (Section 5b). 
Making use of the experience gained from these 'in vitro' 
studies, and 'in vivo ' experiment al study was undert a.1<en in do gs 1 
in an attempt to determine whether or not fibroblast vi ability 
is maintained following implantation of an allograft valve, and 
whether or not such viability could be shown to influence valve 
structure and function ( Section 6 ). 
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Additionally, a personal assessment was made of a 
consecutive group of 100 patients having allograf-t aort ic valves 
inserted between 1967 and 1972 at the Nat ional Heart Hospital 
with a standard surgical technique, but with changes in the 
preparation of the allograft valve (Section 3c). 
A personal review of Reconstruction of Ri ght Ventricular 
Outflow with a valved homograft conduit (reported in 1974) describes_ 
National Heart Hospital experience with this form of surgery 
(Section 3d). 
The remainder of the Thesis consists of a review of the 
experimental work relevant to the field, and the evolution of 
clinical allograft heart valve transplantation (Sections 3a and 




ALLOGRAFT HEART VALVE TRANSPLANTATION IN CLINICAL PRACTICE 
3a EXP~RIMENTAL BASIS AND EVOLUTION OF CLINICAL ALLOGRAFT 
HEART VALVE TRANSPLANTATION 
Initial Experimental Work: 
The first detailed experimental study of aortic valve 
allografts was reported by Lam, Aram and Munnel l in 1952 
(Lam et al., 1952) from the Henry Ford Hospital, Detroit. 
It is of interest that even in this early report the authors 
state that "it was wondered if such a valve homograft might have 
an equal or better chance of success than the plastic valvular 
prostheses of Campbell and of Hufnagel". The relative merits of 
allograft valves, other tissue valves, and prosthetic valves are 
still debated (Karp et al., 1974) and with parallel improvements 
in allograft heart valve techniques and prosthetic valve design 
have provided grounds for debate for many years (McGoon , 1971). 
Lam's group used the canine aortic valve, removed under 
sterile conditions, and transplanted this into the descending 
thoracic aorta of dogs I either immediately, or following storage 
in Tyrode's solution for up to two weeks . In an initial series 
of 27 dogs 7 survived long enough for sacrifice between 1 and 6 
months. The valves implanted into these 7 dogs showed increasing 
loss of functional capacity due to shrivelling of the cusps and 
thrombosis. It appeared that such a valve graft offered no 
promise of success and the authors' conclusion agreed with that 
of Hufnagel , 1951 ) who had earlier mentioned his own lack of 
success with the allograft valve . 
Lam' s group then investi gate,i a second series of dogs in 
which an at t empt was made to allow function of the implanted valve 
by r endering the recipient's own aortic valve i ncompetent . {)f 
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Of 48 a n imals only 18 live d for one ~onth or more - and 
their i mplante d v a lve s wer ~ inspected a f ter 1 to 16 months . 
In 9 of the 18 survivors th e i MP l anted v a lve leaflets 
apyiroxirn a ted the nonnal i n a ppe arance , although there was 
difficulty in de:nonstra ting t h e ir fun c tion due t r) spontaneous 
correction of the rec i pient ' s aortic valve insufficiency by 
adaptation of the uninjured leaflets. 
The au t hors s pe culated that in the presence of permanent 
aortic insufficiency an allograft valve might function 
indefinitely. 
The experimen t al model used by Lam's group - ins ert ion 
of a valve within its cuff of aortic root and adjacent myo -
cardium into the descending aorta, together with i nduction 
of re gurgitation in the host animal' s own aortic valve to 
provide a. stimulus for fun c tion of the implanted valve -
has been appli e d by other workers (Brewin, 1956; Duran 
_et al. , 1965; Duran and ','lhitehead , 1956; Beall et al. , 
1 961 ). 
Clinical Application by Murray in Toronto: 
Murray et al .,(1956) s ~owed experimentally that allograft 
v alves would functi on in the presence o f aortic regur g itation 
of the host and u s ed allo gr a ft valves in the descending aorta 
of 6 patients a-; treatment for aortic r e gurg ita tion . These 
valves ha d b e e n re . wved a.septical ly a nd ke pt in a ·saline 
penicillin !lliYture at 4 °c for u n to 5 wee k s . Hurray ( 1960) 
and Kerwin et a l . (1962) r enorte d well ma inta ined f unct ion 
in the se va lves, and a ga in in 1 964 Bi e elow e t a l . (1964) 
renorted 5 of Murra y ' s p~ti e n ts t o be doing we ll b e twe e n 2 
a nd Bt· year s after i ns e r ti on o f t heir v ;:i.lv e , a n d Heimb e c '<er 
(1 ~68 ) reoorterl g ood f,mc t ion 7 t o 1 5 years l a t er . 
17 
Stud-r o_f Beall, · .. rorr i s , Cool e y and DeBakey : 
A study of the f a te of allogr a f t aortic valves renorted 
by Beall tl al. (1961) showed more promising results than 
preceding stud i es . In t ~is study the aor tic v alve was 
r emoved from donor dogs under sterile conditions a nd 
refrigera t e d from 2 to 28 hours in an antibiotic electrolyte 
solution. Such v a lves were placed in 25 animals in the 
descending t~oracic aorta, and the ho s t dog ' s aortic valve 
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was made incompe tent by avulsing a leaf let wi t h a ho ok passed via 
the subcl avian ar t e ry. 4 operat ive de a t hs and 5 deaths in 
the f irst month occurred, le aving 16 animals for study 1 to 
1 3 month s a fter opera tion . Of the 13 whi ch h ad b een examined 
after death the v alve s of 9 showed slight thickening of the 
l eaflet s , but they remained pliable a n d c a~able of function . 
During t he first month af t er insertion the leaflets mi cro-
sco uical ly showed -polymor ph a nd lymphocytic infil trat ion , a.nd 
over a period o f months the leaflets developed an a.cellular 
appe arance . Competence could not be de monstrated in 4 of the 
1 3 ; 2 of the s e v a lves were in good condit i on a n d 2 were 
shrunken , and it wa s thought th a t loss of func t ion ,in these 
tw o valves was associ a ted with spontan e ous di s a ryp e a rance of 
t he aor tic i nsuf f iciency i n the animal ' s own aor ti c valves. 
The same group als o re J orted the u s e of a ortic valve 
a llografts in the descenciing aorta of 3 ps.tien ts , wi t ::i 
clinic a l improvement 7, 6 and 5 mon t hs af t e r opera tion 
respectively. 
Aortic Valve Replac emen t in t he sub-corona rv Posi tion : 
The u se o f the all ogra~ t aor ti c v a lve in the descending 
aort a was 9ar a l le ll e d b y t he u s e of a pros thetic va lve in the 
same site ( Hufnagel e t al ., 1954 and 1958) . In 1960 the f i rs t 
succes sful clinic a l a or tic v a lve repl a ce ment b y a ball-valve 
in the sub-coronary position was performe d by Har 1<:en (1 960) 
and this achievemen t was ma tc hed by Donald Ros s in 1962 with 
an a ll ograf t valve ( Ross , 1962) . 
Duran and Gunning (196 2) reported tha t they h a d con-
firmed the f inding-s of Lam et a l. (1 95 2), Murray e t al. (195 6) 
and Beall et a l. (1961) a n d described a me thod for r e P.1oving 
the aortic v a lve f rom cadavers , fas hioning it, a nd inserting 
it in the subcoronary p os i t i on. 
The technique of Duran and Gunni ng was applied 
clin ic a lly in Jul y 1962 by Ross (Ross , 1962 ) who successfully 
i mp l anted a freeze - dri e d allograf t aortic valve into a 43 ye a r 
old man wi th se v ere aor ti c s tenosis . In 1964 Ross was able 
to re port 12 pa tient s who h ad undergone a ortic v a lve r eplace-
ment with an ethylene oxide sterilised and freeze dried al lograft 
a ortic va lve (Ro ss , 1964). Of considerable interes t an~ 
relevance to curren t pract i ce in t his f i e ld i s a statenent in 
the discussion b y Ross that ....... "I t i s realised tha t these 
v al v es are not living homog r af t s but t hey s ee8 to be accepted 
b y t he host a n d fu n ction satis factor i ly . They do , however , 
open the way to living homograft valve reolacements once t he 
i •1rnunological problems are overcome . On the other h and t he 
an ti genicity of the cu sps may be low, being v-Lrtua 1. ly av:.=isculRr 
struc t ures '.'. 
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Very s hortly after the pioneering wor k of Ross i n 
Lond on, Barr3 tt-Boye s performe d the first a ortic h o mog ra.ft 
valve r e9laceme n t a t Gre en La ne Hos ~ital, Aukl a nd, New Zeal and , 
a centre de s tined to become f anous f or its u se o f allogr a ft 
valve tissue. (Ba rratt-Boyes, 1964). Between Augu s t, 1962 
and the end of 1968, 590 aortic homograf t valve re9lacements 
were pe rformed in this centre ( Ba rratt-Boye s and Roche, 1969). 
It was shown t h a t the mortality for this surgery was comparable 
to that for i ~plantation of prosthetic v alves ; that e mboli do 
not originate fro m a horno graft valve, and that incompetence 
is unconmon. 
Following the succes s of Ross in London and Ba rratt -
Boye s in New Zealand the use of allog r a ft h eart v a lves was 
more widely adopted . In addition such valves were used, 
mounted on a ·.fr ame or wi t :1. in a supporting tube, to replace 
the r1itral valve and tricus pid valve, a nd used to gether with 
the ascending aorta as ~ v a lved condu it it found a pplic a tion 
in the reconstruction of t he ri ght ventricul a r outflow in 
cert a in congenital c ardi a c condit i on s . ( Angell et al ., 1968 a nd 
1967; Ra stelli et al ., 1 96 9 and 1967; Ro s s a nd So mmerville, 
1966; Ya coub a nd Kittl e , 1 9 6 9 ; Gon z a lez-La vin and Ro s s , 1 970; 
Karo and Kirklin, 1969; Sti n son et a l. , 1 968; W2.l l a ce et a l. , 
1969 and 1971). 
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With inc reasing c l in i c Rl u s e o f allogr a ft heart 
v a lve s in t he .li d - 1 ';) 60 ' s it c:: oon bec a!"!1e cl e2.r t ha t t'.'lese 
valves had a dvan t a;e s over t he t he n avai l s bl e or os thetic 
vslves. The s e <.", dva nt ages we r e absen ce of t h rombo - emboli c 
comolications , l a ck of n eed f or a nti-coagul a nts , absence of 
h a e molys is, good '.'lae mody n am i c per f ormance , and freedom from 
sudden me chan ical .fa ilure . (Ba rratt - Boyes a nd Roche , 1969 ; 
Ross, 1966; Angell et al_ ., 1968). 
Howe ver, the dis a dva nt ages of allog r a ft v a lve s also 
be c a.me clear. Th ese were t h e difficulty in obtaining a 
large supply of s u itable v a lves; knowing !:low best to prepare 
and store them; and the occurrence of l a te c han ges in the 
v alves le ad ing to increasingl y sever e v a lve dys f unction which 
requ ired reopera tion in a s i gnificant numb e r of :patients 
( Missen a nd Roberts, 1970 ; Ya c ~ub and Kittle , 1 9 70; 
Hudson , 1966 ; Sn ith, 1967; Bi ge lo w ~ t a l., 1967) . 
The v alves used h9- Hurra y in t h e. de s c ending a.or ta wi th 
clinical succe s s ( n urray ~ al., 195 6 ) a s well o s t he fir s t 
1 6 valve s inserte d by Barratt - Boye s be twe e n 1 96 2 a nd 1964 
( Gavin et al ., 1973a) were removed under ste r ile c onditions 
from c a d avers a nd s t6 r e d i n el e ctrolyte s o l u tions f or 
relatively s hort p e rio ds b e for e i mpl ant a tion a s ' fres h ' 
grafts. 
Obta i n ing s teri le t ifsue f r o~ c adave r s is neithe r 
pra ctica l no r reli able. I n o~der to h a v e a steady suppl y 
of suit able v a lves wit h a satisfac tory r an&e o f s i z es it i s 
n e ce s s a r y t o ~s e r~utine auto p sy sources . V?lves ob t a ined 
unde r t hese con di ti on s are v ery l ikely to be grossl y con-
t an i nated v:itri b nct e ri a orr f·1ngi . Blood c·Jlt~ res t a~e n 
under ster i le conrlitions from inside the heart immed i a t ely 
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after ope ning the ches t of 45 re f ri ~era ted c a d avers between 
6 end L'r8 hours a fter de e. th were positive in 8 5% (Yacoub and 
Kittle, 1970) , and cultures or aortic wa ll stri ps were 
positive in a l l ins t ances . 
Thus it was a pparent that s ome form of sterilisation 
was required . The te c hniques which h a d been applied to 
s terili sation of ar t erial homogr af t se gments were used 
( Fle we t t et a l ., 1955 ; Eastcott et al ., 1954) . The f i rst 
v a lves to be used by Ross h a d in fact been sterilised with 
ethylen e oxide and freeze - dri e d ( Longmore et al ., 1966 ; 
Ross , 1964) . Many techniques f or the sterili s ation and 
preservation o f a llogr af t he art valves were a dvocated, 
including ethylene oxide sterilisation a nd fr e eze - drying 
( Longmore et al., 1966 ; Pickerin.g , 1966) , exposure t o beta-
propiol a ctone (B ~rn es et al ., 1970) , exposure~ formalin 
( Pa neth and O' Bri e n , 1966 ) or i rradiat ion (Mal m et a l ., 1967), 
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followed by fr eeze -drying with stora~e a t room- tempera t ure , 
refri geration , or storage a t - 79°C (Ge r bode , 1970; Rob , 1968) . 
It was also r e cogn i sed t ha t t hes e met:11Jds of 
steril i sation a n d preserva tion carri ed t he ri sk of damaging 
the a llogr a ft valve . The appea:::-anc e of cracks in valve 
leaflets subjected t o freeze - dr ying was repo r ted by Nohri 
et al . (196~ a nd as a. resul t o f this h is -_ group ab andoned this 
method of freezing , f a vo u ring s torag e in 2ot e l yce rol i n 
Rinrrer 1 s s ol u tion a t - B0°C . I npa irrne nt of tensile stren g t h 
o f s trips of p e rica rdium , a orti c wal l, and v a lve l eaflets 
following freeze - dry ing h a d be en d e ~onstrated ( ~s rri s et al . 
1968 ; Kine ~~-~l · , 196 7) . Cl a r~< (1 973 ) also found thcit 
freez in g c=i lt ers th P. ,:1e chan ical beha viour of v::ilvu l ar ti ssue , 
r esn l tj_ n g· in g·ene ~·aJ j_ sed. s ti ffeni.n g . Le a fle t ru9 t u re in 
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beta-propiol a ctone sterjlised valves was re ported by 
s~ith (1967) Pnd decrease in t ensile strength of beta-
propiol actone sterilised tissue was renor t ed by several 
workers ( Pritchard ~al ., 1966 ; Harris ~t al ., 1968 ; 
Mohri ~al ., 1968a) . 
Brock (1968) predic t ed tha t freeze-dried allograft 
v a lves would c alcify and fail in view of his experience with 
freeze-dried aortic graf t s . Calc if ication was re ported in. 
the aortic wall or annul us at 17 to 24 months af ter impl an-
tation in four beta - propiol actone sterilised, valves, two of 
which had been freeze - dried (Smith , 1967). :Missen and 
Roberts (1970) reported calcification in 24 of 39 i mplant e d 
v a lves that had original l y been sterilised with ethylene 
oxide and freeze - dried and had been placed for 9 to 62 mon ths. 
Cusp rupture was seen in 21 of the 39 v2,lves reported 
by Missen and Roberts , and had a ls o been reported by Hudson 
(1 966) in ethylene oxidersterilised and freeze -dried va lves , 
and by Barratt-Boyes and Roche (1969 ) in beta- propiolactone 
sterilised and freeze - dried valves . Barratt-Boyes and Roche 
c onsidered th c t both leaflet rupture and calcifica tion were 
related t o the Tiet hod of prep~r a tion of the valve , and had 
not seen these complications in their untrea ted valves . They 
described a me t hod of antibiotic sterili s ation which they 
hoped would not damage the acid mucopolysaccharides, coll agen 
and elastin which ::.'lake u p the le c1 flet, and recommended Har1\:s 
solution containing penicillin 50 units/ml , streptomycin 
1 rng/P.11 ., kana'.'l;'fCin 1 ng/:,11 . , and 2 1:1 -pho tericj n B 25 up,/ml . 
These workers Joted th ~t the le a fl ets of ~ntreat2d v a lves , 
removed between J ~onths and 5i years af te r i nser tion, 
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contained fibrobl a sts, and conside r ed thn t t hese fibroblasts 
represented host reaction r a ther than survival of graf t e d 
donor fibroblasts . 
Exuer i mental Studies on the Fate of 
Allograf t Heart Valves: 
The clinica l application of heart v a lve transplantation 
stimulated a number of exp erimental studies aimed a t assessing 
the long-term fate of such v a lves. Considerable interest 
centred on the question of the influence of preparation 
t echniques on long-term fate of the v a lves and the question 
of whether or not an immune res p onse occurred . 
Work of Duran and Collea5sUes a t Oxford: 
This group used a canine mo dclsimilar to that desc r ibed 
by Lam et al ., (1952) and Beall et al . (1 961) - in which the 
allogr a ft aortic valve within its sleeve of adjacent myoc ardium 
and aor tic wall i s placed in the descending aorta of a dog 
which has its own aor tic valve d amaged to produce aortic 
r egurgitation t hus inducing t he i mpl an t e d v alve to function. 
In one experiment ( Duran et al., 1965) to demonstrate 
the fate o f the a llogra ft aortic v al ve in the dog they used 
c anine v a lves obtained within 6 hours of deat h a nd stored in 
0 saline or Grass ' s so lution fo r up to 1 4 da ys a t 4 C - conditi ons 
wh ich were consi de re d to ke ep the tissue vi ab le. 
Con si der able techn i cal d i f ficulties were exc2r i enced 
with t nese ex r erime nts - in the gro~p o· 1 8 do ~ s in which 
aortic inc omnet ence of the recipient was not indu ced only 8 
survived b e t ween 1 and 54 days (two of t hese had to be 
s a cri f iced b ecause of por a,legia and t~e remR i ning 6 died of 
massiv e h r: emoT.-rha ge). The al lo gr af t valve leaflets showed 
'\, 
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thickeni n g and r2tn,c t ion in 5 of the 8 , and were n or :na l onl y 
i n the 3 surviving 6 days er l e s s . 
I n the grou p of 20 dogs in which aortic incompetence 
of t oe recipi e:1 t was induced 10 died on t he t able and 6 
survived long enough for examinat i on of the i mp l anted v a lve 
a t 7 days , 22 days , 44 days, 3 months , 10 months and 12 months. 
All the leaflets o f these an ima l s ' allograft v a lve s were thin 
a nd p liable . 
Histolog ical l y t he l ea fl e ts showed a cellul a r infil-
t ration of l ymphocytes, plasma cells and occas iona l polymorphs 
with surface proliferation of fibrobl as ts when examined within 
the first 3 wee k s of imp l ant at ion. 
appeared hyaline and acellular. 
Thereafter the le aflets 
The authors concluded t hat the v a lves in the grou p in 
which a ortic incompetence ha.d been induced i n the recip i ent 
were i n perfect conditi on , i n striking contras t t o t he 
t h ickened l eaflets of t he group without host aorti c incompetence, 
thu s confirming t he need for function for continued graft ed 
v a lve integrit y . 
Although the a uthors assumed the allograf t valves to be 
vi able no t ests were made for vi ability . It is noted t ha t 
although t heir first 15 v al v es were obtained under steri le 
conditions the other 23 were not , as "it was noted that all 
non-steri le specimens be came sterile once placed in Gra ss ' s 
solution f or over 12 hours" . It is thus open to question 
whether the allograft leaflets were in fact vi able i n view of 
t he delay in re Qoval and the nossibility of bacterial con-
ta1nination , as well as the fr,ct t :11:: t v a lves v;ere stored for 
u :,i to 2 wee<:s - by which t ine ti ssue culture crovrth of fr eshly 
procured steril ~ canine l ea flets s tored a t 4°c in electrolyte 
solutions has SLlbsequently been s ,own to be either absent or 
delayed (Reic he nb~ch et a l., 1971) 
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In a later study Duran and 1.Vhi te:1e a d ( 1966) compared 
the fate of fresh allogra. f t v alves with freeze - dried all ograft 
valves using the same technique B.s described in their ea.rlier 
study (Duran et al ., 1965) with aortic incompetence induced 
in the recipient dogs. Again the operative loss es were 
hi ~h ; only 13 of 25 animals receiving fre sh v alves were 
available for s tudy between 6 hours and 12 months, and 15 of 
26 animals receiving ethylene oxide sterilised and freeze-dried 
v a lves were avail a ble for study between 6 hours and 16 months , 
and 5 were retained for long-term studies . 
Histologically, the first changes in the fresh valves 
were seen at 48 hours when the endothelial and fibroblas t 
nuclei of the valve were pale and the valve was slightly 
oedematous . At 22 days ~ ost of the fibrobl as tic nuclei of 
t he v alve had disappe a red; and valves imulanted longer than 
this were devoid of nuclei . 
In the freeze-dried valves nuclear lysis was virtually 
complete between 3 and 6 days . In two valves, implanted 13 
and 16 months the valve was anuclear, de licate and composed 
entirely of coll agen . The siriking difference b e tween the two 
t ypes of valves was t he much quicker loss of nucl e i from the 
freeze-dr i ed v alves . The authors felt that the freeze-dried 
v alves gave the better result in view of the earlier nuclear 
loss and the possibili t y th ~t fibre - endotheli a l organisation 
of com plicating thrombus is prevented . 
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Studies by Mohri ' s groun at Uni versity of Washingt on , Seattle : 
In view of ac cumulating evidence of clinical suc cess with 
a llograft heart v a lve i mp l an t a tion (Bi ge low et a l . , 1964; 
Ro ss , 1964 ; Barratt-Boyes , 1 964) it appeared tha t these 
v alves were not being subjected to t he rejection t hat would 
be expected with al logene ic tissue . 
Clinical s tudies h a d also failed t o detect antibod i es 
in the serum of a llograft valve reci p i ent s (Da vies et al . , 
1965; Hudson , 1966) . It was s uggeste d t hat t he explanation 
ma y be low antigenicity of t he al logr a.ft valve, or the 
" privilege d site" of the sub coronary position . 
A s tudy was t here for e planned to attempt t o evaluate 
t h is problem using dogs ( r1ohr i et al . , 1 967b), and t his work 
was t hen extended to evalua te the fate of viable and non- vi a bl e 
v al v es . 
I n the first report ( Mohri e t al . , 1967b) 2 series of 
dogs were desc ribe d . I n one series , fresh , vi a b le a llograft 
aortic v alves were implanted subcutaneously in 6 dogs . These 
dogs were subsequently given skin grafts re rwved from t he 
v alve donor aaimal and stored for 14 days . Using suitable 
contr ol animals it was shown that the subcut aneously i mvlanted 
v alve did not resu l t in acceleration of s"k:in g r aft rejection . 
Polymorphs and mononuclear cells were present in the i mplan ted 
le Rflets early on ; by 52 days l eafl e ts were n ot identifiable . 
Ly~phoc y t es Rnd plasma cells were nromineYJ.t in the fibrou s 
tissu e surroundin s the im~lR nted ti s s u e . 
The a u t hors ~o int ed out that the subcut a ne ous site for 
i ~plan t ation did seem likAly t o h ave orovided a sufficient 
sti~ulus f0 r se nsitiz~tion . 1'he conclus i oYJ. , t herefore , wns 
th <=J t the al l og r 1Jf t :; ortir, v ~cl ·re demonstrr'ti,ed ln w :_:mti '{enici ty . 
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In a second series, a sing l e aor tic v al ve leafle t, 
wi tJ,_ 2. S!JD ll anount of adj2-c e nt myocardium and aor t a , was 
used e s an al logrRf t r eµ l a c e ~ent for a l eafle t of male 
experimental dogs . Female donomwere chosen for the source 
of fresh v al ves - t hus allowing as sessment of cell or i gin in 
subsequent tissue culture by identificat ion of sex chroma t in 
bodies . Some o f the recipient 'dogs h a d previously been 
sensit i sed by ski n graf t ing from the donor dog . 
All 20 dogs survived t he opera tion - a tribute to t he 
t e c hnique of total circulatory arrest with the aid of 
surface- induced deep hyp othermi a (Mohri et al ., 1966a) . 
3 died within t he first 3 months, and these, together wi t h 
4 others sacrificed at intervals up to 3 months , provided 
the b as is for histological examination . 
The hist olog ical a ppearances were different from tho s e 
of t he subcutaneously i mpl an ted valves . By the 6th day t he 
l eaflet showed increased ground substance, i ncreased s tromal 
conne ctive c ells with mitotic a ctivity , and some polymorphs . 
At 20 days the le;1flets were thickened and had a b unda,n t -plump , 
ova l , and elongated cells with mitotic fi gures . 
and pl a sma cells were not pre sant in the gr a ft. 
Lym :phocyte s 
By the third , 
month the l eafle t continued to be t hickened and showed 
prolifera tion of fibroblastic-type cells with mitosis in the 
v al ve stroma . No dif ferences were observed between the 
v a lves implanted into sensit ise d and n~n- sensitised dogs . 
Tis sue c ii l ture of t he i,nplanted leaflets reveale d 
outgrowth of f ibrobl as tic-ty9e cell s witnin 4 to 5 days . 
Sex chroma.t in bodies were de :nonst r a.ble in 31%, 36% and 28'"/v 
& cell s grown from S]ecimens obtained at 9, 30 and 60 days 
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res t_)ec ti vely . Control fresh aortic leaflets from female 
dogs s howe d sex chromt, tin in 37/? of cells . 
Thus the donor ori g in of the proli ferati n g fibroblastic -
type cell s in the le aflets was concJuded . No difference in 
durability of t he lec1fl e t s in sensitised or non-sensitised 
recipients was noted . 
The study thus sugges ted low antigenicity of the 
allograft a ortic valve , a ooss ible privileged site of the 
subcoronary position , and the absence of graft rejection up 
to 3 months post - implantation, with survival -of transplanted 
donor cells up to 3 months. 
Mohri ' s group (Hohri et al . , 1967a) later reported the 
fate of the re~aining allogrAft le a flets beyond 3 months of 
implantation a nd showed t ha t the initi a l thickening had 
disa9peare d by 4 months, at which time leaflet cellul a rity 
a;)peared normal. A short seg1,1ent of acellulari ty n e ar the base 
of the leaflet at 6 and 10 months was thought possibly to be 
the result of me chanical injury at the time of leaflet 
insertion . Tissue cu lture of transplanted leaflets reve e.le d 
outgrowth of fi brobl as tic - type cells in allspecimens recove ~ed 
u p to 6 months oostoperativelyo Sex chroma tin bodies were 
present in 15% of cells and 16% ofcells from v 2 lves in pla ce 
for 4 and 6 months respectively. Prior sensitiz a tion by skin 
grafting did not alter t he fate of the f r esh alloeraft 
leaflet . 
A simil a.r s t 11dy wit h betap:::-o oiol 2c tone sterilised 
l eaflets sho~ed t~a t a ll don ~r cells a is appe2re d by 40 days 
after transplantation . There was no thic~ening of these 
l eaflets and bet te r oreservati0n of l n,, flet "?li ab il ity. 
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It wascon cluded th a.t 1\rnc ti ona l durab i lity of the 
le afle t was not aifected by the me t h od o f g r af t preparation , 
a lthough betapropiolactone trec: t ed v a lves a ppea red possibly 
bette r than f re sh v a lves . No evidence of graf t r e jection 
was foun d his tological ly u p to 11 months postirnplant a tion , 
and tissue culture of the fr esh allograf t lea flet demonstrat ed 
p e rsistent donor c e lls a t le as t 6 months postimplantation. 
Mohri and his co-workers (Mohri et al ., 196 8b) wen t 
on to compare the long - term f a te of vi abl e and non-viable 
aortic v a lve a llografts . This was stimul a ted by the reports 
of l ea fl e t rupture in non viable le a flets ( Smith, 1967; 
Hudson, 1966). 
Reporting on the dog s op e r ated on for t he ir e a rlier 
studies they noted in the vi able graf t s prominent fibros is 
and scar ring of th e myoc ardium a.nd aortic wall by 12 months. 
The le a f l ets gradually lo st -pliability a:1d sho wed some 
limit ~tion of le af l e t excursion . One l eafl et im pl anted for 
23 months showed retraction of its mar g in with shortening 
o f t he free edge and height of t he leaflet . 1Jarkedly 
ile creased l e8 fl e t cellu l a ri t y was seen b y 11 and 12 months . 
Ti ssue culture growt h wa s d e monst r a bl e from the exulants 
from the free edge of t h e leaflet. Th e percentage of sex 
c hroma tin positive cells fell with time - b eing 37% i n 3 
controls; 32% i n 3 v alves L1pl2nted 2 !".ionths ; 15,0 in 2 
v a lve s i mp l an t ed 6 months ; and 20~ i~ one v al ve i~nlanted 
12 months. 
Eviden ce of connective tiss~e extension over the ho s t-
grr-if t junc ti on fro,!! ,.,0rtr; 2r:d endocs:rd · ,1 1:1 w'.'l Drese ,1t 3 t 
3 months, and bJ 6 nonths a c,Jn:.'lective ti_s~ne s":.e[;th ex tended 
onto the b 2se of t he l eaflet - t~is v~ried in extent f rom 
spec i men t o snecimen . 
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In the non-viable g r af t s ( steril is ed by betapropiolactone) 
the re was less organisa tion a nd scarring of graft myocardium 
and at 121 months le a flets were of n early nor~al thic~nes s 
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with well preserved pliability . Tm .non-vi a bl e g r a fts showed 
disappeara nce of l eafl e t cells by 40 days and acellularity up 
to 6 months. Extension of a connective tissue shea th onto the 
base of the lea fl e ts occurred by 3 months , and g r a dually 
extended . At 1 ye a r sor.ie host substitution of the le a flet 
was seen . 
Thus, persistence of d onor cells up to 1 2 months was 
demonstrated in viable impl anted al lograft valve, but diffuse 
or segmental acellularity were observed in late specimens . 
The non-viable grafts appe a red superior to vi a ble grafts up 
to 12} months bec ause o f better maint a ined leaflet pliability. 
Studies by ? a lo Alto a nd St a nford grouu in Ca lifornia : 
Th e problem of~te failure in chemic a lly tre a ted, 
frozen, irra di a ted, or fr eeze - dr ied a llograft a ortic valves 
prompted the Stanford University g roup to investigate fresh 
valves ( Kosek et a l ., 196 9), This group suggested the 
theoretica l po~sib ility of~ a ble fibrocyte s in such v a lves 
b eing c apable of remoulding and repa ir of the v a lve. They 
described t he features o f a llograf t ve.lves r er.ioved from 11 
of t he 120 pa tien ts in wh om t hey h a d i nserted fresh valves 
during the ure c ed ing 4 years , and in addition, tested fre s h 
allograf t valves in 40 d o g s . 
These workers founJ t h~ t fr ~sh grRr ta r 2 t a i n viable 
i'ibr0cyte s ca:Js b1c of proli fP.7'·:; t i on o~,ii e~ehorat.ion of g round 
sub s tance and coll a~en . ~os t sheath for ·~~ tion ~hove and 
below the lc :, fl e t of t~e allogrift val v e extended a v ar iable 
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dist ance 0n t o t h0 l erif l e t s cn us ing so-,e t :1 i cken i ng e.nd 
ri ~idity , bu t no retraction of t he leaf l e t . So me of 
t he le a flet fibrocytes be c 2~e swollen and increas ed in 
number , with abund ance of gr 8nul a r endop l asmic reticulum 
indicative of ac tive protein synthes is . Within 4 weeks 
t here was pronounced incr ease in mucopolysac charide ground 
substance, separat i ng coll agen fibre s . The pattern of 
coll agen and elast in became disordere d or re placed by 
whorls of new connec tive tis s ue . The worke rs s t a ted t hat 
the prolifera t ing fi brobl as ts thicken the l eafle t 5 to 10 
times normal, t hereby incre a sing its integrity with little 
alteration i n function . 
It was also noted t ha t some fibrobl asts suffered pyknosis , 
karyorrhex i s , and disruption . The change s we r e considerably 
re duced in valves removed after 6 to 12 months, and were 
more mar ked in t he canine than t he human valves . 
I n a l ater study of the role of rejection ( B~ch e t al . , 
1971) this same group c rea t ed a 3-leaf l e t composite mitr a l 
valve , consi s ting of 1 auto gr a f t lea flet ( fro~ t he 
ex perimental an i mal ' s own pulmon ary v a lve ); 1 heterograf t 
leaflet ( porcine) ; and one al logr af t le aflet . Th is f resh, 
cornnos ite va lve was i Mnl an t ed in t he rni t ral posi tion of 20 
dogs , using c a rdiopulmon2ry bypass . ? operative deaths , and 
6 early deaths f r om e ndocarditis occurred ; t he remaining 12 
anjma l s were S?crif i ced between 5 days and 1 year . 
At 5 d2ys all leaf l 3t s s~o~e · hype rcel lul arity, which 
persis t ed i n t :1e ;:;u t ogr2-ft ;>_n.d t :1e ?llog-r::d t a t 3 1:1onths 
(the het e rogr a f t then bein~ rlevoid o~ f ibroblasts). 
T:1ic'.<eri ing 'Jers i stect s t l y~<'ff i n t:1 e 21;. t ogr:,f t 8nd t hP. 
allogr;:ift, and t "te 2.1l o0r;,ft le r flpt WP.S consid ered to be 
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showing n ild dege n e r a tive Ghanges as a resu lt of hos t 
rejecti on . The s tructurR l changes in t he c ani n e a llogra ft 
were s i n ilar to t hose i n the human all ografts , an d this group 
went on to suggest th a t a v oida nce of major ABO inc ompatibil ities 
between donor and r e cipien t would be wise . (The wisdom of 
t h i s sugge stion ~1as subsequently been refuted by Ba lch a nd 
Karp (1 975) who found no relationship betwe en success or 
failure of aor tic valve a llotranspl an t 2. tion and ABO Rhesus 
blood group co mpatibility. It is known th a t ABO blood group 
anti g ens ar e present in rr.any tissues, includ.ing heart and 
blood vessels; and t hat ABO incompatibility in kidney 
transplants can elicit a vi gorous rejection res,ponse (Starzl 
et a l., 1964)) . 
33 
Ot hers h 8ve investi gated t he probl em of re jection i n 
a llograft he a rt valve s . Baue et a l . (1968) confirmed the 
differing res J onse s to allograf t va l ves depending on the 
site of i flpl an t n tion - a cc e lera ted rejection occurred i n 
sensitis e d a n i ma ls i f the leP.flets were placed subcutaneously 
in do g s , but no difference wa s observed between the sens itised 
and non- sensitised groups if the v a lve was placed in t he 
pul mon a ry area . 
Suzuk i e t al . (1 970) compared fresh allogr afts , beta-
propi olactone ster i l ised allografts , and betaprouiolactone 
s t erilised he t erograf t s in the rn i tral position of 29 dogs -
the 23 survivors were exami ned be t ween lan d 29 months . The 
8 fresh a l lo graf t v a l ves showed progressive oedema.taus , 
i nflammat ory reac t ions , vri th a myxo r:iatou s stroma containi n g 
i nflamma tory cells , fibrocytes a nd fibrobl as ts . There were 
v arying areas of fo c al necrosis . These workers noted a 
v ariable r~s ponse between le a flets - some being more nodul a r 
and t hicker than others . They concluded that although the 
v a l v e appeared cell~l a r , vi able a nd covered with endothelium, 
c ontinued fibrobl a stic proliferation suggested t ha t such 
v a lves would e v entu ally become scarred and incompetent . 
Teeter et a l . (1971) , i nve s tigating subcutaneously 
pl a ced allogra ft v alves i n dogs s1J ggested t he possibility 
of a ortic v al v e al lografts in t he s ubcoron a ry position under-
going a chroni c type of rejection t '.a t i E res pon s ible for son e 
of t he g-raft f .ilure . 
Lo we r et a l . (1 360) had d emonstra t ed evi dence of 
rej e ction i n pulr'lon8.ry v a lve rtllogr::dts - t he s e were 
i n filtreted by ry l 2sir1a cells c:.nd rou!lci cells , i n cont rast to 
Put~~rsf t v al vPs whi c h were not . 
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111cKenzie ~_,11 . (1 965 ) showed necrosis occiiri.ng in 
a llogrPft nitral va lves , b u t c~nsidered tha t the findings 
were not due to reject ion . Pa.t on e t al . ( 1967) a nd 
Kwong et al . (1967) suggested th a t a lloeraf t v a lve surv i v al 
wa s improved in dogs treated with Imuran , but clini cal use of 
i mmunosuppressives h a s not been used since the fi rst human 
allografts were not clearly influenced by this treatment 
(Rosa , 1964). 
Heslop et a l (1973) investigated the antigenicity of 
aortic v alve al lografts in rats . This study had the 
adv antage of allowing use of inbred rats of known i sohistogeni.c 
strains . These workers inserted into the abdomina l a orta 
grafts consisting of myocardium and fwr t a with VDlve le aflets 
( anal a gous to clinic a l graft); a ort a only; and le afle ts only . 
Similar grafts were inserted subcutaneously. They were a ble 
to show that antigenicity r es i ded predominantly in the rim of 
t!'le c 2.rdiac muscle (al though a significant contribution from 
donor leucocytes could not be excluded). The antigenicity of 
the · aortic portion was slight , and t he le aflets ,~re auparently 
not imrnunogenic . Hi stology of v a lves implanted for 2 weeks 
in the aorta s ~10wed t h'• t in t he syngeneic graf t s the l eE:f lets 
were cellular 2nd normal; in the allogeneic grafts t h e 
leafl ets were a cellul ar ~nd showed oedema and degeneration 
of coll a g en . 
This appe Prs t o be en i oportant s t uay ; it shows the 
l flc ''.C of Ln.:1un'.)geJ1ici ty of t::"' leP.fl ::- ts, :,,.1t ·9rese ·1 ce of 
i Tirnuno gen i c ity of other co~7onents of the ~rPft ( es?e ci a lly 
t he rmscle) ; but, a lso, it s~~~s tj e rP ~id loss of cells 
i n ~llogenic ] crflet s a ft e r only 2 we G~ s ( relevan t i~ the 
c l1oice of ti~e - scR l e for the ~roJosed ex~erirn n t al s tudy) . 
The 8e valves would hnve been ~on-functi oninff - ~ut t h is 
c anno t be the exnl R~ation of the 8Cellu1Rrity as the non-
f unct loni ng syn gen eic l eafle t s r ema ined cellular . 
Cons i de r a ble ingenuity has b een shown in the 
i mpl a n a tion of a llog r aft c ard i a c v a lves in ex peri~ental 
aninals i n the past ( Willman ~t al .,1 961; Lower , 1 961; 
Nagovern , 1961; Litwak , 1 961; McKenzie et a l ., 1965 ; 
Van Vhet et al ., 1 96 5; Brewin , 1 956 ; Ab s alon , 1961 ; 
Litwak et al ., 1 952 ) but these studies shed litt le light 
on t he question of vi ab ility i n allogr a ft v alves . 
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5b Current applications of allograft heurt valves 
in clinical practice 
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A, s S '.'l. OW!l diR g rar.1 a tic8l ly in Figure 3b- l the Allogrsf t 
aor t ic valve Cfin b e used to re9lace any of the hea~t valves . 
It s riost wides;)read c1i-rrent use is in tv1e re;)l:?.Ce"1en t 
of t he Portie v 8lve . •{ere it is 11 su8lly 91:::C'ed ;_"\ the c1orti. c 
TnA alloJraf t 2or tic 
vrJ.ve i.s tri r1 'P ei to Y·cmo•:e es ;·11 lch els r;'1ssihl::) of the ac1j e r-e'1t 
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cove r in~ of t h e ho s t coron ~ry osti a . A d ,::ruble s11 ture 1 ine 
t echn ique , a s described by ~ a rratt-Boyes Bud Roche (1 969 ) i s 
us ed . For the lo~er suture line e{ther interrupted sutures 
or a c ontinu.,us su ture are nsed - the lower suture line being 
in .ser te d with the valve t u r ned inside-out and push ed through 
the annulus of t he host into the l ef t v entricle . After com-
pletion o f t he lower sutur e line the v 2lve is pulled back up 
into the aor tic root for co~plet ion of the upper suture line . 
Some of the tec hnical points t hat h~ve b een helpful in valve 
inser tion are referred to in Section 3c . 
For repl a cement of othe r cardiac valves it is necessary 
to mount the all ograft aorti c valve on a frane or within a 
supnorting tube . A fr ame - mounted aortic v alve can be inser t ed 
i n to the 1:,ortic annulus e.s well , and t his does allow quic1<:er 
inser tion with reliable accuracy of v alve posi tioning . 
The results of a llograf t repl a cement of the Por tie valve 
are given in detail f or a series of 100 p a tient s operated on 
by Mr . J . Kei t h Ross at the ~a t iona l Hear t Hos~ital in 
Sec tion 3c . The results of al lograft aortic v a lve replace-
ment by :Mr . Donald Ross at -';he Nationa l Heart Hospital a re 
simil ar ( Ros s , 1 975 ) - 311 p 2ti e n t s are reviewed with 10 year 
follow-up . I n t h i s g r oup there has been a 16~ incidence of 
v alve failure, but t his has affect e d t he e arli e r freeze - dried 
v al v es ~ Th e a llogr a ft a atic v a lve re riains the v a lve of 
choice for aortic v a lve r eol a cemen ~ i n thi s c entre . 
The ex oerience wit h t he us e of Pll ograft a or ti c valves 
i n the mitr a l position h Rs no t be en e s satisfa ct or y in man y 
c entres ( A:ne ell ~ t al ., 1975 2, ; Le:cn.o:x , 1 975; 0~ ~t a_l ., 1973) 
and t h i s h u s r e l a ted to long-t erM fal. lure . These v glve s 
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wor <ed we 11 , wit \-, good hr: err1od ynami c uroperties and freedom 
from t ;1ror1boembol ism . H0~ever , th . ex nerience of Yacoub 
(1 975) has been remar~ably good usins the aortic allograft 
va lve mounted in a semi - flexible tub e of dacron . 428 
patients h~d 1n itra l valve reolacernen t by thi s technique 
between P.ugus t 1 ') 69 a11d l'l<-rch 1974 , A very low incidence 
of late complications has been seen, and h2emodynarnic 
perfor mance , and fr eedom [rom thromboerabol i sm and haemo -
lysis , mal(e t h i s the method of choice for mi tra l v alve 
re plac ement for this author . 
Balch and Karp (1 975) re?ort 385 pati~nts h aving 
aortic all ograf t valve re-pl .« cement a t t he Al abama Medi cal 
Cent re betwe en 1968 and 1373. The va lves had been frozen 
0 
to - 72 C end sterilised by irradiation, and ken t for uu to 
6 months before being disc c rded i f not used. 35 failures 
had occurred during t his time in the series of 385 val ves . 
·0ta l lace et .al . (1 974) reuort 229 ?ati ent s undergoing 
eortic all ograft v a lve repl eo cei'lent beh e en M:~"y 1965 and 
Oc t ob e r 1972 at the May o Clj~ i c . The fir s t 92 valves had 
been betapropiolactone sterilised and s tored in Ha nks 
solution; t he r emaining 137 valves had been sterilised by 
0 
i rradi a tion fll :d stored a t -70 C. T~0re were 11 ~o s nital 
de n. th s (4 , Bi,). 20;~ of ~urv.i.vors h a c cc n [,ortic di.P.f'tolic 
r~rn u~ Rt ti nn o f hos n i t e l dt smis 2al - thi s we s t ~P only Qig-
nl f icrnt vari Pb! e in ~redictln~ prob ab i lity o f r9 ou~ra tion 
'')".' v »lve f2 i lure ; no s i. ,sr-1ir'ic Pnt d~ ffei:>enr:e · n l " t e v::ilve 
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An ge ll ~J; 2L, (1 97 3a) r e port e d 189 PBti ents r e ceiv ing 
isol ~t e d aortic repl a c eme nt s a nd f ollowed for 5 years . These 
valves were pr ocured unde r s terile conditions i niti a lly ; but 
l a t e r sterili sed with antibiotics. 5 year survival was BO% 
and half of the death s wer e accounted for by valve - rel a ted 
c au s es ; 30 ( of living p a tients h a d valve - r e l a ted co~plications , 
including r egurgitation o r reoperati on. 
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Figure 3b - 2 
As shown die.gramatically in T<'igure 3b - 2 the alloe;r a ft 
a or t i c v alve c n be used toge ther wit~ the a sc ending aor t a 
and cuff of adjacent rnitra l v alve and n yocardium as a valved 
conduit f~r the reconstruction of t he right v entricul Pr out -
flow in a number o f congenit al cardi 2 c defects . 
Section 3d revi e ws e_',]" ri ence ·,·; " t:1 this u~oc ed11re a t 
T~1e 11sP. of a hono "':r a ft or 
ci. Llo s-r a ft conf,Jit re1,wiri~ t!F Dr oced1J.re of choir,e at this 
centre .for re c ons tru c tion of the ri·-1,··1t ventr j cul':-::- outflow 
(Ross, 1975b) . Con tinn ed go od r esults fro;:i thi s for:,1 of 
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reconstruction were rapo~t e d by Ross and So~erville at th
e 
British Ca rdi2c ::oci e ty Hee ting in 1iover1ber, 197 5 in London . 
ll'IcGoon _tl 81. (1 973) re ·por t ed the use of an a llograf t 
conduit of ascendine aorta including its v alve , between t
he 
right ventr icle and pu l m'1rnL7 artery ( the " Ra stelli opera
tion") . 
In 111 operations at the liayo Clinic the procedure was us
ed 
for recons truction in truncus a rteriosus (55 cases ) , trans -
position of the great arteries with pulmona ry stenosis 
(36 cas es ), pulmonary atresia (11 c ases ) and miscellaneous 
conditions ( 9 c ases ) . Th e operation c arried a hospital 
rnortali ty of 329t for the entire group - worst for 
transposi tion of the g r eat arteries with pulmonary s teno s
is 
under the age of 5 years and patients with truncus arteriosus 
and high pulmon3ry v ascular resistence . This ris k was a 
reflection of the problems associated with t he conditions
, 
and did not imply any difficulty with the use of allograf
t 
condui t s for the reconstruction . 
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3c HOMOGRAF'T AORTIC VALVE REPLACE!4ENT 
A personal review of 100 consecutive patients 
June 1975 --------
SUMMARY 
100 consecutive patients who had isolated aortic valve 
replacement with a homograft valve have been followed for 21 to 
83 months. There were two hospital deaths. 85% of patients 
had competent valves at time of discharge; 14% had mild valve 
incompetence . Anticoagulants were not used and three thrombo-
embolic episodes occurred, confirming the relative freedom of 
homograft valves from this complication. 
Preparation of the homograft valve was altered twice in the 
series in the hC'·pe of reducing the incidence of late valve failure . 
42 ethylene oxide sterilised valves and 26 gamma irradiated valves 
have shown a 30% incidence of valve failure over a 4 to 7 year 
period. 32 antibiotic sterilised valves have not shown valve 
failure over 2 to 4t years, encouraging the hope that these will 
prove more durable than the earlier valves. 
Although homograft heart valves have advantages over 
prosthetic valves, their use has been restricted by concern 
r egarding late valve failure. This has been ascribed to earlier 
I valve preparation techniques and it is hoped that current techniques 
of antibiotic sterilisation will reduce the incidence of such 
failure. 
It is therefore of interest to report 100 consecutive 
patients who had isolated aortic valve replacement with a 
homograft aortic valve between November, 1967 and July, 1972 at 
the National Heart Hospital, London, by Mr. J. Keith Ross or his 
registrar. Surgical technique varied little; but valve pre-
paration was altered from ethylene oxide sterilisation to gamma 
irradiation, and finally to antibiotic sterilisation during the 
series ( Lockey et al. 1972). 
Clinical details 
Of the 100 patients 75 were male and 25 female . 
from 14 years to 67 years ( average 43 years) • 
Ages ranged 
Two patients were symptom-free; 14 were in cardiac failure; 
the remainder had symptoms of either chest pain on effort, syncope, 
or exertional dyspnoea (Grade II or III of th~ New York Heart 
Association classification). 
27 patients gave a history of previous rheumatic fever. 
19 patients had previously been treated for infective endocard.itis . 
The valve lesion was predominently aortic stenosis in 39 
patients (usually calcific), aortic regurgitation in 23 patients 
(often following previous infective endocarditis) , and mixed in 
38 patients. 
59 patients had heavily calcified valves and this frequently 
obscured the likely aetiology , but 28 patients were judged to have 
congenital aortic stenosis, 27 had valves which appeared rheumatic 
in aetiology, and in the remaining 55 the aetiology was uncertain. 
Surgical technique 
All patients were operated on by the median sternotomy 
approach with normothermic cardiopulmonary bypass. 
perfusion was used in all. 
Coronary 
25 patients had additional procedures . 9 of these were 
left ventricular septal myotomy where subvalve hypertrophy was 
judged to be excessive and obstructive , 2 had closure of ventricul ar 
sept al defect, and the remaining 14 had open mi tral val votomy with 
or without annuloplasty, mitral leaflet advancement or tricuspid 
annuloplasty. 
Early in the series an oblique aortotomy was made down to the 
non-coronary sinus; later this was modified to a part~vertical/ 
part-transverse aortotomy which left the host non-coronary sinus 
intact, thereby facilitating placement of the grafted valve 
commissures to avoid distorting its non-coronary sinus (Figure 3c:-1) . 
Aortic root tailoring was used when the root was large. 
Sutures placed beneath the commissures reduced the annulus size 
ensuring an accurate fit for the grafted valve. 
was used in 25 patients (Figure 3c-2). 
This manoeuvre 
Less commonly the aortic root was enlarged by incorporation of 
a Dacron gusset into an oblique aortotomy where a small root had 
been anticipated - especially if t he graft non- coronary leaflet 
appeared likely to prolapse as a result of its conunissures being 
pulled to gether by aortotomy closure . 
patients (1,'igure 3c-3). 
Tnis was done i n 6 
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Initially in the series, and when the ao rtic roo t was small , 
t he l ower sut ure line was of interrupted sutures ; l at er the 
continuous suture technique of Barratt- Boyes was us ed ( Barratt-
Boyes and Roche , 1969). 
Valve preparation 
42 patients received hbmograft aortic valves which had been 
sterilised with ethylene oxide . 34 of these were fl ash f ro zen 
0 to -79 C and stored at that temperature, the rema ining 8 were 
freeze-dried and stored at room temperatur e . 
26 patients received homograft aortic valves which had been 
sterilised by gamma irradiat i on. 21 of these wer e flash froxen 
to - 79°c and stored. at that t emperature, t h e remaining 5 were freeze-
dried and stored at 4°c . 
Most recently in the series, from February 1970, 32 patient s 
have received homograft aortic valves sterilised in antibiotics 
and stored at 4°c in Hank's Solution or Nutrient medium (Lockey 
et al. 1972). 
Follow-up assessment: 
Primary interest has been in the assessment of function of 
the homograft valve. This assessment is not always easy to make 
clinically. It is well recognised that presence or absence of 
symptoms relates poorly to the functional state of the aortic 
valve, and furthermore, the assessment of the clinical find ings 
is not alweys easy, particularly in post-operative patients . It 
i s possible to demonstrate mild to moderate aortic re gur gitation 
angiographically in some patients who show no clinical evidence of 
regurgitation. 
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The clinical appreciation of aortic stenosis can be 
difficult in these patients - a s;ystolic ejection murmur is 
co~monly present from the time of operation and evidence of left 
ventricular hypertrophy may not ent irely regress post-operatively. 
One patient required replacement of a severely stenosed calcified 
homograft aortic valve where clinical recognition of the situation 
was in all probability delayed by the diagnostic difficulties. 
This is an uncommon manifestation of valve failure - increasing 
regurgitation is the usual consequence. 
Recognising these difficulties an attempt was made to 
assess clinically the functional state of the homograft valve. 
Information has been obtained from clinical, radiological and 
electrocardiographic findings at 6-rnonthly .hospital visits in 
the majority; in the rest referring physicians have supplied the 
necessary data. Findings at re',operation have provided 
incontrovertible evidence in cases of valve failure. 
At follow-up patients have been grouped into the following 
categories :-
A Normal ly functioning valve. Here there is no clinical 
evidence of valve stenosis or incompetence. 
B Mild valve d,ysfunction. Here clinical evidence of a minor 
leak is present (sufficient to give rise to a diastolic 
murmur, but no other evidence of regurgitation). 
C 
D 
Moderate valve dysfunction. Clinical evidence of more 
important regurgitation is present in addition to a 
diastolic murmur. 
Severe valve qysfunction. 
to warrant re-operation. 
Here dysfunction is severe enough 
Most in this category have in fact 
undergone re-operation which has confirmed valve failure. 
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RESULTS 
In the series of 100 patients there were 2 hospital deaths. 
4 patients who have left the country cannot be traced; one died 
at two months, and 93 are available for follow-up. 
Ethylene Oxide Sterilised Valves 
In the group of 42 patients who received homograft aortic 
valves sterilised with ethylene oxide there was one hospital death 
on the first post-operative da;y from low output state. This 
patient had had infective endocarditis and had pre-operatively 
suffered a major infarct of his l eft ventricle following a 
coronary embolus. 
Follow-up is available for 39 patients in this group. 
At present 12 have normally functioning valves (category A) 
at between 54 and 82 months (average 68 months) after surgery. 
A further 12 have mild valve dysfunction (category B) at 
between 60 and 83 months (average 69 months) after surgery. 9 
of these changed from A to B between 2 and 50 months (average 19 
months) and 3 have been stable in this category for 78, 77 and 
62 months respectively. 
3 patients have moderate valve dysfunction (category C) at 
60, 72 and 82 months respectively - one initially A changed to C 
at 12 months; one initially B changed to Cat 29 months, and one 
has remained stable in this category for 82 months. 
One patient of this group died at 28 months of carcinoma of 
the breast,the homograft valve having fu.~ctioneru normally 
( category A). 
11 patients have required r eplacement, having deteriorated 
into category D between 27 and 67 months (average 48 mont hs) post-
oper atively and re-opera.tion has been performed i n 10 of these at 
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an average of one month l ate r. In only one did infective 
endocarditis at 25 months appear to be a factor in deterioration 
of the valve. In 9 the patient was in category A for between 2 
and 37 months (average 19 months)i in 2 the patient was in 
category B immediately after the original operation for 20 months . 
and 15 months respectively. 
Figure 3c-4 shows in histogram form the functional status 
of the ethylene oxide sterilised homograft valves at each year after 
surgery. Follow-up as yet does not extend to 5 and 6 years in all 
but the trend of an increasing proportion of dysfunctioning valves 
with time is clear. 
Gamma Irradiated Valves: 
In the group of 26 patients who received valves sterilised 
by gamma irradiation there was one death at 2 months after surgery -
valve function had been satisfactory at time of discharge but the 
patient developed signs of mild aortic regurgitation prior to 
sustaining a fatal hemiplegia overseas. This valve was not pro-
cessed .at the National Heart Hospital, and in retrospect, its early 
failure, almost certainly complicated by infection, seems related 
to its preparation. 
Follow-up is available for 24 patients in this group. 
At present 5 have nonnally functioning valves (category A) 
at between 49 and 66 months (average 59 months) after surgery. 
A further 8 have mild valve dysfunction (category B) at 
between 49 and 77 months ( average 68 months ) after surgery. 7 
of these changed from A to B between 4 and 66 months ( average 
36 months ) and one has remained in category B from the time of 
operation for 72 months. 
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3 patients have moderate valve dysfunction ( cat e gory C) - 2 
having changed from A to Cat 70 and 72 months respectively, and one 
having been initially B changed to Cat 46 months. 
8 have required replacement, having det eriorated into category 
D between 7 and 76 months (average 51 months) and operation has 
been performed in 7 of these at an average of 2 months later. No 
evidence of infective endocarditis was present in any. 
Deterioration had been gradual in 4; relatively rapid - over a f ew 
weeks - in 4. 
Figure 3c-5 shows in histogr~~ form the functional status of 
the gamma irradiated homog'I'aft valves at each year aft er surgery. 
Again, an increasing proportion of dysfunctioning valves with t ime 
is apparent. 
Antibiotic Sterilised Valves: 
In the group of 32 patients who received antibiotic sterilised 
valves there was one hospital death - an unexpected sudden death 
attributed to a dysrhythmia which occurred on the 4th post-operative 
day - and autopsy failed to show any valve-related cause for death. 
There have been 2 late deaths not related to the valve at 
36 months (systemic lupus erythematosus) and 12 months (myocardial 
infarction). Autopsies in both showed the homograft valve to be 
satisfactory, confirming the clinical assessments ( category A). 
Follow-up has been unobtainable i n one case. 
Of the 30 available for follow-up 19 have no r mally functioning 
valves (category A) at between 21 and 43 months (aver age 33 mont hs ) 
after surgery. 
8 have mild valve dy sfunction (category B) at between 30 and 
55 months (aver a ge 39 mont hs). 7 of thes e changed f r om A at 
betw een 2 and 55 mont hs (avera ge 19 mont hs ); one has been i n 
cat egory B from t he time of operation for 41 mont hs . 
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One patievit has moderat e valve dysfunction (category C) 
at 40 months, having changed from B at 4 months . 
None has r equired replacement . 
Figure 3c-6 shows in histogram form the funct i onal status 
of t he antibiotic sterili sed valves at each year after surgery. 
The short follow-up for this . group cl early makes comparison with 
the other groups difficult. 
Thr ombo-embolism 
Patients have not routinely been anticoagulated aft er surgery. 
Apart from the patient who diecl at 2 months with hemipl egia two 
patients had minor embol ic episodes - one a hemipar esis at 3 months , 
and one a transient blindness of one eye at 2 weeks. The relative 
freedom of homograft valves from thromboembolism is confirmed in 
this series. 
Re-ope rat ion 
Re-operation has been undertaken in 17 patients with 3 deaths. 
7 patients had a second homograft valve inserted (antibiotic 
sterilised) without mortality and these valves are functioning 
normally at this stage (between 3 and 30 months post-operatively). 
9 patients had prosthetic valves inserted, and one had a 
fascia lata valve which in turn was replaced by a Starr Edwards 
valve after 5 years. 
T'ne findings at re-operation were s imilar in all. 
Calcification of the homograft valve, particularly at the bases 
of the l eaflets, was present in variabl e degree. Fenestrations 
and tears of t he leaflets had resul ted in severe regurgitat i on in 
all except one where extensive calcification had caused such leaflet 
rigidity that stenosis had occurred . 
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Histologically, theleaflets were homogenous cell-free 
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DISCUSSION 
This series clearly demonstrates the feasibility of 
replacing the aortic valve with a homograft valve with low 
operative mortality - the two hospital deaths in the 100 patients 
do not appear to be related to the type of valve used. other 
series have demonstrated low hospital mortality of the order of 
5% which has been at least as good as that for prosthetic valves 
(Wallace et al. 1974; Ross, 1972; Karp et al., 1974). ---
Technically, homograft valve insertion is more demanding 
than prosthetic valve insertion but the points outlined in 
surgical technique were found helpful. An early diastolic murmur 
at the time of hospital discharge has been taken as being indicative 
of slight malposition of the homograft valve and was present in 15% 
of patients in this series. This is similar to other reported 
series (Wallace et al., 1974; Angell et al., 1973a) 
The homograft aortic valve remains a good substitute for 
the diseased aortic valve in spite of continuing improvements a.Y\d 
modifications in prosthetic valve design (Ross, 1972). Relative 
freedom from thrombo-embolism and excellent haemodynamic properties 
are their · main advantages. The low incidenc~ of thrombo-embolism 
without anticoagulation in this series is in keeping with that 
reported by other centres (Wallace et al. , 197 4 ; Karp et al ., 197 4; 
Barratt-Boyes and Roche, 1969). 
However, from the time of the first clinical horno~aft valve 
replacement i n 1962 (Ross, 1962) concern has been expressed about 
long-term integrity of such valves. Late valve failure has been 
ascribed to earlier preparation techniques (Barratt-Boyes and P~che, 
1969 ; Gavin et al. , 1973b) and antibiotic sterilisation has been 
adopted in the expectation of reducing the incidence of late failure 
(Angell et al., 1973a). 
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Ethylene oxide sterilised valves have been followed for 
between 54 and 83 months (average 69 months) in this series and 
11 of the 39 patients have required replacement for valve failure. 
However, 24 still have normally functioning valves or mild 
regurgitation evident only as a diastolic murmur. 
In the group of 24 gamma irradiated valves followed for 
between 49 and 77 months (average 65 months) 8 have required 
replacement for valve failure while 13 still have competent or 
mildly regurgitant valves. 
Comparison with the antibiotic sterilised homograft valves 
in the group of 30 is difficult in view of the shorter follow-up 
period (21 to 55 months - average 35 months) but none has required 
replacement and 27 have competent or mildly regurgitant valves. 
In the first two groups ( ethylene oxide sterilised and g~1lilla 
irradiated valves) there is thus about a 30% incidence of valve 
failure requiring re-operation over a follow-up period of 4 to 7 
years. 
Wallace et al. (1974) report 34 patients of 218 with beta-
propiolactone sterilised or irradiated valves requiring replacement 
between 4 and 91 months (average 42 months). Karp et al. (1974) 
estimate that 10 to 15% of patients with irradiated homografts will 
need replacement at 5 to 6 years. 
Barratt-Boyes and Roche (1969), Ross (1972) and Angell et al. 
(1973) report good results with antibiotic sterilised valves, although 
Gavin et al . (1973) report that the pathological changes in such 
valves following removal from patients are qualitatively similar to 
those observed in chemically sterilised valves although there are 
quantitative differences. Clearly further follow-up data is 
required, particularly in this reported series , but this series 
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does demonstrate the unsatisfactory long-term failure rate in 
ethylene oxide sterilised and gamma irradiated valves and shows 
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outflow with a va lved ho~ograft c onduit. Since 1966 a 
condui t of homo gr a ft as cending adr t a wi th its valve has been 
used f or re construction of t he right vent r icular outflow. 
This technique ha s been applied to 1 23 operati ons for 
pulmonary autogra f t rep l acement of the aor tic valve , 48 
operations for correction af severe Fallot ' s t e t ralogy or 
pul monary a tre sia , five operations f or t r uncus a rteriosus , 
two oper at ions for transposition of the great arteri e s with 
v entricula r s ep t a l defect , and six ope r a tions for tr icusp i d 
atre s i a o r common ventricle . EPse of i nsert ion and 
s a ti sfac tory func t ion have encouraged us in t he use of 
t h i s form of conduit . 
The proble:n of provi ding an adequat e pa t hway for blood 
fr o~ t he righ t ventri c l e to r each t ~e nulmonary art eri es 
arises in a number of cerdiac surgica l procedures . These 
include se vere ~arms of Fal lot ' s t e tral ogy, pulmonary a tresia, 
t runcus ar t e riosus , and transposition o f the gr eat ar t s ries 
with ven tr i cul or sept a l defect . 
I n 1966 a condui t o~ homogr af t a scending aort a with its 
v alve was first use d to solve th i s n~obl em in a Jatient with 
pul~onary a tresie ( Ross and ~onervi l e , 1966) . The pPtient 
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SU~GIC ~L TSCJNI~UE 
The homo ~r of-t condu i t c on s i ,., t s o f es c ending s or t a with 
it s valve toce th a r wit h rennants o f the anter ior l ea flet of 
the ,"l i tra l v a lve . ~h i s ti ssue is obt a ined a t routine 
necro ps y within 48 hours of death and is curren tl y sterili zed 
and s tored a t 4°c in an an tibiotic-nutrient med ium (Lockey , 
Al - J anab i, Gonzales - Lavin , and Ross , 1972) . 
The i nser tion of tte conduit presents few technical 
problems . The graft i s trimmed to a suitable leng th and the 
coron ary orifices of the gr af t a re sutured . The graft is 
po s itioned t o t ake advan t Age of its n a tural curva ture, thus 
reducing distortion of the v a lve . The distal end of the 
g r a ft i s anas tomos ed with a c ontinu ::ms s uture t o the ouened-
out di s tal pulmonary art e ry or the region of the pulmonary 
art e ry bifurcation and may be ex tended out into one or other 
pul rn ona ry ar t ery as required . Proximally the graft is 
' count e rsunk' as f a r as pos, ibl e into the righ t v entricle to 
give a sati sfactory angle o f origin ; this requires trimr1 ing 
of t ~e edg es of t he righ t ven triculotomy . There is usually 
a defect _oresent an t eriorly between the g::-aft and the ri gh t 
ventricl e and t his i s closed with a Dacron or pericardial 
gusse t (Fig . 1) . 
The conduit function s well a nd provides a competent 
v a lve for the right v e ntricular outfl ow . Calcifi c ation 
co 111:11only 2,,9~ears in t he 8ortic wall of th2 eraft and is 
vi sib le radiolog ically after ab:m t six "l ont:i s . Howe ver , it 
does not BfJpear to i 1'lpair v :i lvc function nor inv'Jlve the 
cusps ( SoMe rvill e And Ros 2 , 1972) . 
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bonsiderable exoerience hrs b een ga ined in r econstructing 
t he rig~t v8ntricnlar out - flo•,! •.vi t h a ho1:1.o!='.'r"ft cond1 i t in 
in t he ooeration of aor t ic valve replace~ent ~ith oulmonary 
autograf t ( GonzRle s - Lavin, Geens, Sonerville , and Ross , 1970). 
Since 1967 , 123 oye r at ions for aortic valve replacenent ha ve 
been ~e rforrned using the , ntient ' s autoge nous 9ulmonary va l ve , 
which is ex c is ed early in the course of the operation once 
t he need for replacement of the aortic v a lve has been 
confirme d (Fi~1re 3d- 2). 
The pulmonary va lve offers an ideal v alve for replace -
~ent, no t hfving been exoo s ed to s t erilizati on or storage 
t echniques . The ooeration i s technically demanding and it 
has been limited to younger pa tient s . 
o r 0ble .1s reJatin~ to the use of homo s r a ft s i ~ this a,pl ication 
o:" ri gh t ventric '1lE,r 0"1 tfl ov: rec:mst r 1J.~ t i.on. I n the srou,;i 
of 1? 5 pati en t r there have been 16 hos~it a l dea t hs and t hree 
l e te rleaths . Resul t s i n t he survivors are gra t ifying (Ro ss , 
1972). Thirty-five of t~1es e 1rn ti ents ha ve h2d nornally 
functioning homograft out fl ow conduits for five years or 
more. One of the l a t e deQt j s occurre d e t five a nd a ha l f 
y9ars ; no expl anation w~~ fou~rl eni the h o~~cre ft v2lve in 
t ',e right ventricul2.r out.f'loT -·:2.s re;~ar'-<:c>,Ole f')r it 2 /:.0:::'i"JP.J 
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type 1 or t y pe 11 ( ~omervill e , 1970 ) , Bnd 24 t o h a v e sev ere 
Fa llot ' s tetralogy with a hypopl as tic infu nd ibulurn , pulmonary 
v a lve ring , or main riulmonary artery , t he d i s tinc tion may be 
difficult to ma~e preoper&tively, a nd from a surgical point 
o f vi ew t h ey e r e v a rying degrees of t he s arae bas ic problem . 
I ndeed soine p a ti ent s who hav e b e en shovm to h a ve severe 
Fallot ' s tetralogy prior to sys t enic-pulmonary a n astomos is 
h a v e on r e - investiga tion failed to opacify the right 
ventricular outflow, and the appearance a t surgery h as been 
of pulmonary atres i a . 
I n t h i s difficult g r ou p of 48 pati ents t he re h a v e been 
21 hospital deaths . Reconstructi on of the ri ght ventricular 
outflow wi th a valved homo g r a.f t conduit h 2-. s not been 
t echnical ly diff icu l t, a lthough in one c as e e problem a ro s e 
fr0m compress i on of t he g r af t by t he ~t ernum on clo sure of 
t he c he s t. Th i s was ap?reci&ted onl y af t e r re - opening of 
t he c hes t for lo w c a rdiac output s tate, and t~e pa ti ent 
sub s equently died . 
The 2ge r ange of t his gr~up was 18 months t o 34 years 
( T2 bil e I) . The 18 mon t h - ol d ch ild was u ~suc ce ssfully 
operated on under e~ergency conditions followi n g c ardi a c 
arrest during left thor a c oto ~y fo r a Blaloc k anas t o1uosis . 
Pr evi ous palli a tive s y s teMi c - 9ulnonary anastomoses 
were presen t i n 37 of t he prt i 9n t s (TPhle II). 
were closed as P ureli1'! in2r y steJ to co:rrection . I n sane 
p ~ti en t s a nrevious WR t e r Fto n palli r tive anastomosis 
aJpeR r e d tn hPve ~ i nked t~2 ri a~ t nul~0n2ry 3rterv 0nd led 
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pati e nt n it WR~ necessnry to dissect t ~e ri ;h t pulraona ry 
ar. t"'ry off t ,1e 2or t "' i:i t t "'e ·,,: 2. t ,e r c: t on <'! nPs tor10~:is 8nd 
u~ t c h t~e r ight pulmonRr v Frt e ry t o enl ~r ge it ~t t he 
sh i_n t s it e • 
A v ertic Al incision h~s been urefe rr.ad in t he right 
ve n tricul a r outflow where t h e out.f l ow i s known to be a t re tic 
or n:.> rrowed as this inci sion c en readily be extended up into 
tne pulmonary ar tery if necessary (Fi gure 3d - 3), The 
coronary ar t erial anatomy must be borne in mind in planning 
the incision . An anoma.lous left a n terior descending artery 
is a particul a r h a z a rd ; division of such a vessel led to t h e 
death of one of our patients . 
I n all c ases t he ve n tricular se ry tal defect was patched 
with Dacron cloth (one p~ ti en t had three ven tricul a r se~tal 
defects) . I n addition Rn atrial se~tal de fect wa s closed 
i n four pa tie nts. Oth e r procedures required et the time of 
c 0rrection (in edd ition t o clo s ure of any ~y 0 te~ ic-pulmona ry 
anastonos is) Are shown in Ta ble III . 
The major cause of d e a th wa s f ai lure to relieve ri €h t 
ven tricul a r hypertension (T ab le IV) , ri ght ve n tricul a r 
pr essure usunlly being equal to or i n excess of l e ft 
vent ricular pressure hmediately af ter c orrection. This 
was associ 8 ted with a pro gres sivel y f al ling art2ri2 l P0
2 
and 
b leed ing fror1 the condu it ;,,n2.s tomo tic lines . I n 10 Nt i e:1 ts 
died, unresolved r i ght ventr icul a r hyper t ens i on was t he 
m2j or f ac tor in the de~t~. T:1 is was no t due to obs tric t ion 
i n th e homosr rf t conduit, and pressures i n t h9 dist~l 
T~e SP~e ~roblem 
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pu l.1T1o n Ftry v a sculAr resist a nce due to high flow sys t e 1nic 
connection s , or h ypoplast i c pulmona ry ve s sels well out into 
the lungs , h ?ve explained these dea t hs . 
The r at io of r i gh t to left v entr i cul~r presRure 
af t er c orre ction on the oper8 ting table h a s g iven a fairly 
good indic a tion of t he prognosis (Tab l e V) . In 19 of the 
27 survivors t he ri g h t ventricul a r uressure was half or le ss 
than half of the left ventricle . 
There was one totally unex~laine d death a t two months, 
where the right v entricular outflow rec onstruction looked 
entirely satisfactory a t post - morte :-n exaftlination . Results 
i n t he survivors have been good and t here has been no evidence 
of dysfunctj_ on of t he hoinograf t conduit , with the exception 
of one pa tient wh o se central v enous pressure remained elevated 
P,nd was shown t o have 8 , g r a dient of 60 mmHg a cros s t h e conduit 
11 days af t e r surgery . I n seven p a tients t he condu it has 
functioned wel l for over five ye a rs . 
conduit function i s shown i n Table VI . 
Durc,.tion of ho E10gr9f t 
CORRECTION OF TRU NCUS AR.TERIOSUS Correction of truncus 
ar t eriosus has b een limited t o fi v e cases i n our ex~er i ence . 
There were two deatha . The pulmonar y arteries were isol a ted 
from the truncus and the v entricular septal defect w~s closed, 
af t e r which a v alved aortic flO l'.l OgT2"ft conduit WS S US"?-d . to 
recons titute 2. ri e;ht ventr icnlc:r out f low in the usual nanner 
describ e d (McGoon, Ra stelli , ~n~ On gl ey , 1968 ; ~el do n 2nd 
Cameron, 1968) ( Fi g . 3d- 4) , 
cmrn ·~CTION OF TRAN0 l?O STTION O~'I'i-{~ GR -~A'11 ~dTE:RI SS ',VITH 
VENTR1CUL 1 R SE0 T! L DSF8CT ~x ~e rien ce with correction of 
trRns po s it i0n of th e ~r e2t ~rt 0 ri es wit h v e ~tricul 3r s ept r l 
defe ct ,:1d Jeft v c ntri.cn J p r ')'l t f;.o ·,1 t r~ct ob f;tru ··: ti. , n h :t s 
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been l init ed to two c RseR . Af t er placin~ a patch to 
redi-ect left v entr icul 2r blood through t he ve ~tricular 
se pt8 l nefect into the Gort~ a condu i t of h ono 0ra ft aor t a 
is usea t o rec ons truct a right ven tr icular outflow - the 
prox i ~Pl end of t he divi ded pulmonary art e ry having f irst 
bee n oversewn (Ras telli, HcGoon , a nd Wa llace , 196 9) 
,( Figure 3d- 5) . 
CORRECTIO/ 01" TRICUSPID ~TR°:::SI . AWD QORRECTION OF 
CO'T~'.ON VE~TTRICLE Recentl y thi s tec hn ique has be en applied 
in a modified form t o t he 11roble!::s of tricusp i d a tre sia and 
to co amon ventricle . Here the right a trium is ad a9ted to 
f unc t ion a.s a. ' right ve ntri c le ' and a conduit is u s ed as a 
ri ght ven tricul ar outflow ( Fontan and Baude t, 1971 ; Ross 
a n d So!:lerville, 1973) ( F i gu re 3d - 6). 
Two of the four tr icus~id Dtres i a ry a tients have 
survived, but t he two c oumon ventricle m:, ti ents vre re near -
ter~in a l when op er a ted on and d i d n ot survive pos toperatively . 
Ho wever, initial f unct i on was promis i ng and it i s possible 
t ha t t'.1e t echnique may have BD'J lic a t ion i n thi s f i eld. 
DISCUSSION 
The need f or cons t ruction of an outflow tr act for t he 
right ventricl e i s co 1;11a on to many conditions . The tee hr..iq_ue 
of usins a va lved conduit as outlin<: t- i. s one E";:)roe:oc:h to t ._'o 
·9:r.oblem (~foGoon , Wa ll ace , e•,rl i'a:1. i elson , 1973) , This 
tec"lniq1.1e hBs ,<sive,: s[: t.i sfecto::"y re s' il ts in 0ur e):Der ience 
well 1'1 S in oths:' ce11tres (3 ?\':2.e :y et 91 . , 1972 ). ?owever, 
fu rt~er obse rv ~ti on i s r eqiired befo r~ t~e lon ~- t e r~ fate of 
~uch ~ condu i t CAD be ~sse~se2 . 
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Various other c~nd uits 3re curr ently in u se 
( Kouchou'.(os , ~E rci a , 3 argeron, and Kir~lin, 1971), tubes 
of Dacron with or withou t !)rosthetic, heterogrs ft or ho ,no- · 
g r ~f t v2lves g iving sati s fectory re sults in othe r c entres . 
Our e arly exper ience with tubes made of fasci a lata con-
t a ining a fascial valve was uniformly unsuccessful in 11 
pat ien ts (Ro ss and SoCTerville , 1971) . We have been conc erned 
abou t the poss ible adver se effect of pulmonary r e~1rgita tion 
wher e a v a lve is not use d , and prosthetic v a lves may be 
res~onsible for silent t hromboeobol ism to the lung s . 
Results of using hornogr a ft aortic segr.1ents to replace 
sections of the aorta re se cted for e.neurysn or coarcte,t ion 
showed t h~ t although calcification i sheavy i n t~e non-viable 
gr a ft s t he ir function as c ond~its i s-re tained for eight to 17 
ye ers af ter i1'lplrintation (Br '1c1.< , 1968) . Long-ter~ re sults 
foll ow i ng '.'lo ,no s-r af t aor tj_c v Rlve i r~ular. t &tion suggAs t t hat 
reasonable long-t erra va lve function c on be ex9ected, and t~e 
use of vi &.b l e ho :n ogra.ft t issue i11a.y i11 prove t he ou tloo1.c further 
(B2rratt-Boyes , 1 ) 71 ; £1.ngell, Shur:iwP.y, and Kose1<, 1972 ; 
Ro ss , 1972 ) . Although it ma y appea r t hat a homogr~ft aorta 
with it s valve used in t he pul~onary posi tion may l ns t 
longer, a s it i s subjec te d to lower pressures , the obser-
v a tion of bett e r su rvival of ~u l ~onery grR ft R over aortic 
gr 2. fts has b een r enort ed in experfr1ente l c onoi_t L ms 
(rn,.,, =, l e .,,, T ,rp·':--"'r "n;a 
\ -- J.... A • L ' ~L ~ _ • ·_; . . . ' f . ._ ~ t l 
··•',_i~t rri, 1 97';·) . 
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.r ~0 .ir~,i itation I'1 :0 y be ben.i ,:::1 , it r.H'Y not be well toler.s.ted 
where t here is an i ncrease in pulmonary vAsculAr r es ista~ce . 
Al though we continue t o DP: · : 0:i.ge the outflo 1, ' t ras t of }'al lot ' s 
t etralogy by p2tc~1ing whe ~::, necessary , t he severer f orms of 
outflow tra ct hy9 oplasia a~uear t o have been more sa tisfac-
t orily dealt wi t h by the use of a homograf t aortic conduit 
with its valve . Good l ong- ter::i f unc tion to date and eas e 
of insert ion of the conduits have encouraged us in their 





TAB LE I 
SEV~;R E; FALLOT ' S TETRALOGY/ 1YJT?:fONARY ATRSS IA. 
Age a t ope r a ti on and r e l a tion to hosuital death 
Age (yr) 
Under 2 
2 - 4 
5 - 12 
Over 12 











SSVERE FALLOT ' S Tii:I1RALOGY/PUU,'[ONARY A'I'R8S I A. 
Previous sys t em ic- pulmonary anas t omoses 
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Wa t ers ton 
Blaloc1( 
Potts 
~R t e r ston+Bl a loc~ 
"fh t8rs ton+El a l oe '·(+Pott. s 
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S 8VERc;; FALLOT ' S 'T'STRATJOGY/PULNOT'L~ 1iY ATR1•~SIA : 
Rieht/left v entri culP r pre ssure after correc tion 
No . of Patients Deaths 
--
Less than 70% 27 6 
More than 70;1~ 11 10 
TABLE VI 
SEV~3.E :? ALLOT ' S '11ETRfl_tOGY/PULMONA:=?Y ~.TREST .A : 
Du r a tion of h omogr a ft cond~it function 









Figure 3d - 1 
VVt 
. ·:-sc. ·.'\ 
Reconstruction of right ventricular 
outflow - homograft conduit in place. 
.... -- ....... -
(a) (c) 
Figure 3d - 2 (a, b ) Pulmonary valve excised for use in 
aortic position; (c) Right ventricular outflow reconstituted 
with homograf t. 




ready fOlr' insertion 
Right vent r icuhr outflow reconstruction in 
Figure 3d - 4 Correction of truncus arteriosus. 
J?ulmonary arteries isolated from truncus and 







Figure 3d - 5 Correction of transposition of great arteries. 
Patch directs blood via ventricular septal defect to aorta . 
Figur e 3d - 6 
Reconstruction for 
tri cuspi d atresi a or 
corrrnon ventricle 
Valved homogr af' t 
conduit 
ect closed 
r, ounted homograi't 
inferior vena cava 
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SECTION 4 
AIMS OF INVESTIGATION 
The aims of the investigation were as follows:-
1) To determine the effe ct of antibiotic 
sterilisation and storage on heart valve . 
fibroblast viability. 
2) To determine whether fibroblast viabil_ity is 
maintained following isotopic allotransplantation 
of a viable valve. 
3) To determine whether, in antibiotic sterilised 
v,~lves, the state of fibroblast viability can be 
shown to influence valve structure and function 
following isotopic allotransplantation. 
Definition of Terms for Purposes of this Investigation: 
Antibiotic sterilisation and storage. 
This refers to the exposure of a heart valve intended for 
transplantation (i.e. valve leaflets with cuff of adjacent vessel 
and myocardium) to a mixture of antibiotics in a cell nutrient 
medium, and their storage at 4°c for up to 8 weeks in the same 
mixture. The particular mixture used. in this investigation is 
that in clinical use at the Nat ional Heart Hospital I London, and 
recommended. by Waterworth et al. (197 4). Details of this mixture 
are given in Figure 5a-1. 
Heart valve. 
Heart valve refers to an aortic or pulmonary valve, which 
consists of three leaflets, together ·with the valve annulus a.'1d. 
adjacent cuff of myocardium and. vessel wall. 
Fibroblast viability. 
All investigations of viability have been made on the leaflets 
of the valve , since it is the fate of the leaflets which is 
important, and since previous workers have similarly investigated 
leaflet viability (Reichenbach et al. 1971; Gavin et al. 1973c; 
Mohri et al. 1967a, 1967b, 1968; Buch et al. 1971; Kosek et al . 
1969). The definition of viability is difficult as the various 
cellular functions by which cells or tissues are recognised as 
being living or 'viable' are impaired or lost at va:r".{ing rates 
following cell injury or deprivation of oxygen or nutrients. 
It has therefore been necessary to define viability in terms 
of particular parameters of cellular function , and a large number 
of methods have been described for the assessment of cell or 
tissue viability (Malinin and Perry , 1967). 
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The most commonly used method of assessing heart valve 
leaflet viability has been the demonstration of growth of 
conne ctive tissue cells (fibroblasts) from the leaflet tissue 
in tissue culture (Angell et al. 1973b; Reichenbach et al. 1971; 
Mohre et al. 1967a; Buch et al. 1971 ). Tissue culture of valve 
leaflets is relatively simple and unequivocal, and its wide use 
by previous workers makes this method an essential choice for one 
method of defining viability. 
In an attempt to define viability in more quantitative terms 
the autoradiographic demonstration of tritiated thymidine 
incorporation into nuclear desoxyribonucleic acid has been 
described by Al-Janabi et al.(1972). This same group (Al-Janabi 
et al. 1973) subsequently described assessment of protein synthesis 
by heart valves by measuring uptake .of isotopically-labelled proline. 
This method appeared to offer a particularly relevant assessment 
for this study in view of the postulated continued protein and 
collagen synthesis by implanted allog~aft valves (Angell et al. 
1973a; Lockey et al. 1972). Measurement of protein and collagen 
synthesis by measuring uptake of tri tiated prol ine was therefore 
used as a further parameter of viability. 
Thus , for this investigation, viability of the cells of the 
heart valve leaflets (fibrocytes - or fibroblasts, as they are 
known when young, active, or growing in tissue culture) has been 
defined in two ways: 
1) Ability to grow in tissue culture, and 
2) Ability to synthesise protein and collagen. 
As will be shown in Section Sa, canine valves obtained from 
healthy animals within} hour of death can be shown to be viable 
in tenns of being 1) able to show fibroblast growth in tissue 
culture, and 2) able to synthesise protein arid collagen. 
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After one week of storage in Antibiotic-Nutrient ·solution these 
valves show no impairment of viability using these criteria . 
Howevert with increasing storage time the ability to synthesise 
protein and coll agen is lost but ability to show fibroblast growth 
in tissue culture is ret ained for longer. 
After 4 weeks of storage i n Antibiotic-Nutrient Solution 
viability could not be demonstrated using these criteria. 
A further parameter of l eaflet vi ability which as been applied 
in assessing viabi lity is t he presence or absence of cells in 
histological sections. Clearly , if cells are totally absent the 
particular piece of tissue s een is not viable - this has been used 
as a criterion for non-viability by many workers (Duran and 
Whitehead, 1966; Duran et al., 1965; Mohri et al .t 1968 ; 
Angell et al., 1973a; Gavin et al ., 1973a). 
With the evidence concern ing the state of viability o:' canine 
valves removed within t hour of death and stored in Antibiotic-
Nutrient Solution presented in Section 5a, it would appear 
satisfactory to assume viability in such valves if stored f or 
less than one week; and non-viability if stored in excess of 
4 weeks. In the animal stndy described in Section 6 these 
assumptions were confirmed by assessing tissue culture grow~h of 
control valves in each case. 
Isotonic allotransolantation. 
Allotransplantation is taken to mea:..'l the r emoval of tissue 
from one individual and its i nsertion into another individual of 
the same species (e.g. human to human , or dog to dog) . The term 
homotransplantation or homo grafting is synonomous . An allograft 
or homo graft t is thus transplanted tissue from the same species. 
77 
An isotopic graft is a graft to the same site within the 
recipient as the tissue occupied in the donor - e.g. aortic valve 
of donor grafted to aortic valve position in recipient. 
Precise definition is required in view of the known difference 
in the fate of heart valves transplant ed into differing sites in 
the recipient animal (e.g. subcutaneously implanted leaflets evoke 
an inflammatory response and disappear, but subcoronary implanted 
leaflets do not - Mohri et al., 1967). 
Valve structure and function : 
Retraction, thickening, distorsion .or rupture of leaflets 
have been noted in valves failing clinically (Gavin et al. 1973a; 
Hudson, 1966). It has been suggested that proliferating 
fibroblasts thicken the implanted leaflets, increasing integrit y 
with little alteration in function (Angell et al. 1973a). Tnus 
in this investigation valve structure and function will be assessed 
by noting changes in leaflet dimensions and the ability of the 
valve to function as a competent, non-obstructive valve. 
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5a TISSUE CULTURE, PROTEIN AND COLLAGEN SYNTHESIS IN 
ANTIBIOTIC STERILISED CANI NE HEART VALVES 
McGregor, C.G. A., Bradley, J.F., McGee, J.O.D., and Wheatley, D. J. 
from 
SUMMARY 
Departments of Pathology, Victoria and 
Royal Infirmaries, Glasgow 
Viability of canine heart1valve leaflet fibroblasts was 
assessed after varying periods of sterilisation and storage in 
antibiotic-nutrient solution. Tissue culture and assessment of 
protein and collagen synthesis showed that tissue obtained under 
optimal conditions rarely retains viability beyond 3 weeks in 
antibiotic-nutrient solution and is severely impaired after two 
weeks. 
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Fibroblast viability in heart valves prepared by 
antibiotic sterilisation for grafting has been considered an 
important factor in ensuring long-term integrity of the implanted 
valve (Angell et al. , 1973a; Lockey et al., 1972). 
Many methods have been employed to assess fibroblast 
viability, including tissue culture (Angell et al. , 1973b ), 
autoradiography (Al-Janabi et al. , 197 2), protein synthetic 
activity (Al-Janabi et al., 1973), electron microscopy ( Gavin 
et al ., 1973) and selectivity in uptake or exclusion of dyes by 
fibroblasts (Chalcroft et al., 1974 ). 
Tissue culture has been widely used to assess viability 
as it is unequivocal and relatively simple but it lacks quantitation 
in t hat the proportion of viable cells in a piece of tissue is not 
det ermined. Ultrastructural changes in antibiotic sterilised 
cani ne valve l eaflets have been shown not to be uniformly distri-
buted (Gavin et al ., 1973 ) indicating the need for a quantitat ive 
method for viability assessment . A technique of measuring 
14c-proline uptake , as described in a preliminary report by 
Al-Janabi et al. ( 1973)gives a quantitative assessment of f ibroblast 
viability. 
For valid experimental studies adequate quantities of fresh 
healthy tissue are required. Pract ical difficulties in obtaining 
such tissue f rom human sources has necessitated the use of animal 
tissue. Canine tissue has been al most extensively investigated 
by previous workers in this field (Angell et al. , 1973a; 
Hammon et al. , 1974; Duran et al. , 1965; Gavin et al. , 1973; 
Re ichebach et al. , 1971). 
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1his section reports a study of the effects of antibiotic 
sterilisation and storage on the viability of canine valve leaflet 
fibroblasts using a combination of tissue culture and assessment 
of protein and collagen synthetic activity. Many antibiotic 
combinations have been used for sterilisation of heart valves 
in clinical practice; we have used the antibiotic formula 
recommended by Waterworth et al. (1974) in Nutrient medium as 
used in clinical homo graft preparation .(Al-Janabi, 197 4) 
Figure 5a-1. 
COMPOSITION Of ANTIBIOTIC-NUTRIENT SCl.UTION 500 ml 
(Wlterworth et al 1974; AI-Janabi 19741 
Antibiotics in Sterile Water Nutrient Medium Composition 
Benzylpenicillin Sterile water 3'll ml 
500 mg in 2.5 ml water 
Gentamycin sulphate TC 199 (IOx cond • 44 ml 
500 mg in 2.5 ml water 
.Polymixi n B Sulphate Calf Serum No l • 35 ml 
5 mg in l ml water 
lvystati n 
1, 250,CXXJ units in 50 ml water 4.4% Sodium bicarbonate 25 ml 
56 ml 444 ml 
• Wellcome Reagents Limited, Beckenham, Kent. 
F i .:sure 5R - 1 
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MATERIALS AND METHODS 
Source of Tissue: 
Aortic and pulmonary valves were removed within t hour of 
death from healthy dogs being destroyed at a Local Authority 
Home. Those for immediate assessment were removed under sterile 
conditions; the remainder were placed in freshly mixed Antibiotic 
Nutrient Solution (Figure 5a-1) and placed in storage at 4°c 
within 3 hours of procurement. The aortic and pulmonary valves 
from each animal were stored together, with adjacent cuffs of 
vessel and myocardium in 100 ml of Antibiotic Nutrient Solution 
as described for clinical homograft valve storage (Lockey et al., 
1972) for up to 8 weeks. 
Tissue Culture: 
A primary explant technique was used. After excision of 
the leaflets from the stored tissue each leaflet was thoroughly 
washed sequentially in three 10 ml volumes of TC199* to remove 
excess antibiotics. Leaflet tissue wcSminced with scissors and 
placed between plastic coverslips (Thermanox R)** lying in a Petri 
dish to which nutrient medium (TC199* with 30% foetal bovine serum 
with added glutamine 2 mIVI) was ad.ded. The tissue was incubated 
at 37°c in a moist atmosphere of 95% air a.~d 5% carbon dioxide. 
Assessment and feeding were done at 48 hour intervals. Growth 
was arbitrarily defined using a scale of+ to+++ as shown in 
Egure 5a-2. Cultures were kept for 4 weeks. 
Protein and Collagen Synthesis: 
The ability of each valve to synthesise protein and collagen 
was assessed as a means of testing tissue viability. Each valve 
was divided into two aliquots and chopped finely with scissors. 
* from Wellcome Reagents Limited, Beckenham, Kent. 
** from Lux Scientific Corporation, California 91360. 
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One half of each valve was boD.ed in Minimum Essential Medium 
(Gibco-Biocult-Scotland) for 15 minutes before incubation with 
isotope. This served cS a control. Both halves of each valve 
were then incubated in 5 mls of Minimum Essential Medium containing 
5pCi of 3,4-3H proline at 37°C. for 3 hours in a 95% o2 and 5% CO2 
atmosphere. After the incubation the tissue was recovered by 
centrifugation at 2,000 g for 15 minutes. The tissue was then 
resuspended in 0.05 M Tris, pH 7.6 and homogenised in a Silverson 
Emulsifier. Protein concentrat ion in the homogenate was measured 
by the method of Lowry et al. (1951) using bovine serum albumin as 
a standard. 
Protein synthesised by each valve was measured in duplicate 
by spotting 200 ul of the homogenate into 3 MM Whatman filter paper 
discs. The discs were then processed through 10% and 5% trichloro-
acetic acid, ethanol ether (3:1 V/v) and dried in ether; each wash 
lasted 30 minutes. The radioactivity in each disc was then 
measured in a liquid scintillation counter using Brayts solution 
as fluor cocktail. 
The amount of collagen synthesised by each valve was measured 
as follows. Trichloroacetic acid was added to the homogenate to a 
t"inal concent ration of 10%,. The precipitated protein was recovered 
by centrifugation and the collagen extracted from the pellet with 
2 ml 5% trichloroacetic acid at 90°c for 30 minutes. The 
supernatant was removed by centrifugation and dialysed overnight 
against tap water. The total amount of newly synthesised collagen 
present in the dial;y:sed supernatant was measured by the method of 
Peterkofsky and Diegelmann (1971). The amount of protein and 
collagen synthesised by each valve is expressed as cpm/mg of 
tissue protein or dpm/mg tissue protein used in each incubation. 
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Figure 
5a - 2 
Figure 
5a - 3 
+ ++ +++ 
Arbitrary scale for grading tissue culture ; rowth 
+ Early cellul ar outgrowth from explant 
++ Outgrowth established from entire edge of ex:._olant 
+++ Confluent sheet of cells 
~ +GROWTH ~++GROWTH II +++ GROWTH 
Key to Figures 5a - 3 to 5a - 7 
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Ten fresh aortic and ten fresh pulmonary leaflets were 
assessed for growth in tissue culture. All specimens showed 
growth. Earliest fibroblast outgrowth ( + growth) was evident 
at 3 or 4 d.zy-s and a confluent sheet of fibroblasts(+++ growth) 
was established in all by 9 days (Figure Sa-3). 
pulmonary leaflets behaved identically. 
Stored Valves: 
Aortic and 
18 out of 20 valves (9 aortic and 9 pulmonary) stored for 
up to one week showed growth comparable to fresh valves (Figure 
5a-4). 
37 of 40 valves (18 aortic and 19 pulmonary) stored for 
one to two weeks showed growth which proceeded more slowly 
(Figure 5a-5) • 
28 of 40 valves (14 aortic and 14 pulmonary) stored for 
two to three weeks showed growth which was still further del.zy-ed 
(Figure 5a-6). 
11 of 40 valves ( 5 aortic and 6 pulmonary) stored for three 
to four weeks showed growth which was markedly delayed (Figure 5a-7 ), 
and in fact the pulmonary and aortic valves of only one animal could 
be grown after 26 days of storage. 
No new growth occurred later than twelve days in tissue culture. 
None of the 40 valves stored for more than four weeks showed 
growth in tissue culture. 
Protein and Collagen Synthesis 
The ability of each stored valve to synthesise protein and 
collagen was used as an index of tissue viability. Three aortic 
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and three pulmonary valves were removed from storage at intervals 
from 1 - 8 weeks and checked in this way. Four freshly removed 
aortic and four pulmonary valves were similarly assessed. As 
shown in Figures Sa-8 and Sa-9 valves stored for 1 weeks are 
capable of protein and collagen synthesis, but this synthetic 
activity declines rapidly thereafter such that they are incapable 
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DISCUSSION 
Canine valves assessed in this &udy were obtained under 
opt imal conditions for maintenance of viability . Tissue culture 
gro~rth, and prot e in and collagen synthetic activity, could be 
readily demonstrated in all such fresh tissue examined . After 
storage for up to one week in Antibiotic Nutrient Medium, no 
obvious impairment of viability was noted using the assessments 
described. However, the adverse effects of storage in Antibiotic 
Nutrient Medium became evident with storage times of more than 
1 week. 
After storage for between 1 and 2 weeks tissue culture 
growth was delayed, and after storage for between 2 and 3 weeks, 
there was failure of growth in 30% of specimens, and del ayed growth 
in the remainder. After storage f or between 3 and 4 weeks only 
28% of specimens showed growth and this growth was delayed. None 
of the valves stored for more than 4 weeks in Antibiotic Nutrient 
Medium showed tissue culture evidence of viability. 
Protein and collagen synthesis was not impaired after 1 week 
of storage in Antibiotic Nutrient Medium but after 2 weeks protein 
synthesis was considerably reduced and collagen synthesis was not 
d.etectable. After more than 3 weeks of such storage virtually no 
1 
protein synthesis was demonst rable. 
Tnese findings are simi lar to thos e of Reichenbach et al. 
( 1971) who found that canine aortic valves would not show growth 
in tissue cul ture after storage in Waymouth medium for more thaY\ 
14 days at 4°c, although it is i ntereting t hat when stored at 37°c 
in Waymouth medium tissue culture growth could be demonstrated after 
5 weeks of storage . 'I'hese workers did not use antibiotics in the 
storage media , and it would t herefore appear that the antibiotics 
in this study did not severely impair viability . 
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The work of Gavin et al. ( 1973c) who found significant 
cellular damage on electromicroscopy after only one week in 
Hanks' solution, and more severe damage in cells exposed to 
antibiotics, also supports the findings of this study. 
Thus, in canine valves obtained under optimal conditions, 
viability can only be retained with any degree of reliability 
for up to 2 weeks of storage in Antibiotic Nutrient Medium . 
After this period viability is considerably impaired and is 
virtually absent after 3 weeks. 
Such conditions are impossible to achieve in routine 
human autopsy material. This must therefore cast considerable 
. doubt on the concept of valve viability in clinical heart valve 
transplantation where storage periods of up to eight weeks are 
described for antibiotic sterilised valves (Al-Janabi , 1975b). 
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5b VIABILITY IN HUMAN HEART VALVES PREPARED FOR GRAFTING 
McGregor, C.G.A., Bradley, J.F., McGee , J.O.D. and Wheatley, D. J. 
from 
Departments of Pathology, 
Victoria and Royal Infirmaries, Glasgow 
SUMMARY 
Viability of antibiotic sterilised and stored human heart 
valves obtained at routine autopsy was assessed by tissue culture, 
and protein and collagen synthesis. 
Only 3 of 23 examined showed any evidence of viability, in 
striking contrast to the earlier work (Section 5a) on canine 
valves obtained under optimal conditions. These findings 
justify doubts regarding pre-implantation viability in human 
heart valves prepared for grafting. 
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Transplantation of allograft heart valves is an accepted 
method for replacement of diseased valves (Angell et al., 1973a; 
Ross , 1972; Barratt-Boyes and Roche, 1969) and for reconstruction 
in certain congenital cardiac defects (Wheatley et al., 1974) . 
Structural changes have occurred in transplanted allograft 
valves leading to late valve dysfunction detracting from otherwise 
excellent clinical results from a nwnber of centres (Wallace et al ., 
1974; Missen and Roberts , 1970; Karp et al. , 1974; Aparicio et al. , 
1975). These changes have been ascribed to earlier methods used 
for valve sterilisation and storage, such as exposure to 
betapropio-lactone, ethylene oxide or gamma irradiation with 
subsequent freezing (Smith , 1967; Hudson, 1966). 
Initial good results with fresh valves prompted the 
suggestion that viable donor fibroblasts may be an important 
factor in long-term structural integrity (Mohri et al., 1968; 
Kosek et al., 1969; Buch et al., 1971) and that these viable 
fibroblasts may continue to synthesise collagen and remould and 
repair the implanted allograft valve (Lockey et al., 1972; 
Al- Janabi et al., 1972; Angell et al., 1973b; Hammon et al., 197 4). 
Procurement of fresh human tissue is clearly impractical 
and of uncertain sterility (Yacoub and Kittle, 1970). Use, 
therefore, has to be made of routine autopsy material which is 
inevitably heavily contaminated and in which cellular degeneration 
has had time to occur. Many formulae of antibiotic combinations 
have been suggested to achieve sterj_lity while retaining fibroblast 
viability (Angell et al., 1973b). Waterworth et al. (1974) have 
assessed the efficacy of sterilisation with different antibiotic 
formulae and recommended a mixture of Penicillin, Genta~ycin, 
Polymixin B sulphate and Nystatin, with nutrient medium added in 
an attempt to retain viability (Lockey et al., 1972) (Figure 5a-1) 
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In the study of viability in antibiotic sterilised and 
stored canine heart valves (Section 5a) using tissue culture, 
protein and collagen synthesis, it was found that viability 
-· 
was considerably impaired after 2 weeks of storage. That study 
showed failure of tissue culture growth in 30% of 40 specimens 
stored between 2 and 3 weeks and failure in 72% of 40 specimens 
stored between 3 and 4 weeks. Similarly protein and collagen 
synthetic activity declined rapidly after 1 week of storage; 
collagen synthesis in fact being undetectable after 2 weeks. 
The antibiotic nutrient formula used was that recommended for 
clinical use by Waterworth et al. (1 974). T'ne canine valves 
studied were obtained under optimal conditions for the 
maintenance of viability and sterility, in that they were removed 
irrunediately after death. These conditions cannot be obtained 
in the autopsy room and this raised serious doubts about the 
viability of human valves collected for clinical use. 
This section, therefore, reports a study of viability in 
human valve tissue removed at autopsy for potential valve 
replacement. Clinical criteria were applied in the selection 
of valves and viability was assessed by means of tissue culture 
and quantitative assessment of protein and collagen synthesis . 
The methods used in this study are identical to those in the 
canine study and shown to be reproducible. 
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MATERIALS AND METHODS 
Human aortic valves were removed at routine autopsy subject 
to th·e following criteria: patients were under 55 years of age 1 
without intrinsic valvular heart disease, and death-to-autopsy 
period was less than 48 hours. Details are shown in Figure 5b-1. 
The valves were placed immediately in antibiotic nutrient solution 
(Figure 5a-1) and stored at 4°c. Six valves were assessed within 
24 hours; seventeen valves were assessed at periods of 1 to 8 weeks 
as shown in Figure 5b-1. 
A primary explant technique for tissue culture was used as 
described for the canine valve study (Section 5a). 
Protein and collagen synthesis was assessed using tritiated 
praline uptake as described in the canine study (Section 5a). 
The praline uptake and tissue culture studies were performed in 
separate laboratories and each group's results were unknown to 
the other. 
95 
HUMAN VALVES IN ANTIBIOTIC NUTRIENT MEDI UM 
Time of Assessment 
Wthin 24 hours 
(6 valves) 
After 1 week 
After 2 weeks 
After 3 weeks 
After 5 weeks 


























* Growth in tissue culture demonstrable. 
Figure 5 b - 1 




























Of the entire group of 23 valves only 3 showed growth in 
tissue culture - these being a 45 year old patient with 9 hour 
autopsy delay and 24 hour antibiotic exposure; a 41 year old 
with 12 hours autopsy delczy and 1 week of antibiotic exposure; 
and a 28 year old with 6 hour autopsy delay and 2 weeks of 
antibiotic exposure (Figure 5b-1). 
Protein and Collagen Synthesis: 
Protein and collagen synthesis was undetectable in all 
except the valve of the 28 year old with 6 hour autopsy delczy 
and 2 weeks of antibiotic exposure, which showed protein 
synthesis at a level of 1,000 cpm/mg tissue protein a.nd no 
detectable collagen synthetic activity. 
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DISCUSSION 
This study has shown that for practical purposes human 
heart valves obtained at routine autopsy for clinical trans-
plantation are rarely viable. In fact, only 3 of the 23 assessed 
grew in tissue culture and protein synthetic activity at a low 
level could be demonstrated in only one. 
This may not be surprising considering the inevitable 
post-mortem cellular degeneration and infection which must affect 
the valve fibroblasts. Interestingly, the valve which did show 
tissue culture growth and protein synthesis was removed from a 
young patient only 6 hours aft er death. 
Our findings conflict with those of Al-Janabi et al. (1972) 
who report fibroblast growth by tissue culture in 70% of valves 
obtained within 48 hours of death and stored up to 4 weeks. The 
disparity may be explained by our stricter criteria for tissue 
culture growth. Also Al-Janabi et al. (1973) report protein 
synthetic activity in a small number of valve leaflets after 
antibiotic storage. However, it must be pointed out that the 
levels of activity reported were extremely low even after only 
24 hours' storage when compared with the values reported by our 
group for fresh and 1-week stored canine tissue (Section 5a). 
Furthermore, the methodology described may not adequately have 
removed free 14c-Proline from the estimations. 
The findings reported in thisµi.per are support ed by those 
of Gavin et al. (1 973c) who found significant cellular damage on 
electromicroscopy after only one week in Hanks' solution and more 
severe damage in cells exposed to antibiotics. 
The doubts r a ised by this study regarding pre-implantation 
viability in clinical allo gTaft valve practice must cl early also 




IN VIVO STUDY OF POST-IMPLANTATION VIABILITY 
OF HEART VALVE LEAFLETS 
The aims of this stu~y were: 
TO DETERMINE WHETHER FIBROBLAST VIABILITY IS MAINTAili"'ED 
FOLLOWING ISOTOPIC ALLOTRANSPLANTATION OF A VIABLE VALVE. 
and 
TO DETERMINE WHETHER, IN ANTIBIOTIC STERILISED VALVES, THE 
STATE OF FIBROBLAST VIABILITY CAN BE SHOWN TO INFLUENCE VALVE 
S'rRUCTURE AND FUNC'11ION FOLLOWING ISOTOPIC ALLOTRANSPLANTATION. 
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6a DESIGN OF ANIMAL MODEL 
Need for Animal Model: 
Opportunities for examining transplanted antibiotic 
sterilised heart valves in clinical practice are relatively 
uncommon. Valve failure with antibiotic sterilised valves is 
less common than with the earlier chemically sterilised and 
frozen, or irradiated and frozen valves (Ross, 1975; Gavin et al. 
1973; Angell et al. 1973), thus fewer are removed. In the series 
of 100 valves reported in Section 3c none of the antibiotic 
sterilised valves had failed, and two recovered at autopsy 
following non-valve-related death were reported as being grossly 
normal but were not available for histological examination. 
Those valves removed for reasons of valve failure may not 
be representative of the majority of valves which function normally. 
Gavin et al. (1973a) were able to report six 'fresh' valves removed 
up to 8-t years after implantation, a.~d 4 of these were removed 
because of valve failure. Gavin et al. (1973b) further reported 
42 antibiotic sterilised valves removed up to 3! years after 
implantation, but 16 of these were removed for valve failure and 
22 were recovered at autopsy following hospit~l death - leaving 
only 4 recovered from patients dying late from non-valve-related 
causes. Kosek et al. (1969) reported 11 fresh valves removed 
from patients who died or required valve replacement. Similarly, 
of about 400 fresh grafts used at the National Heart Hospital only 
100 
11 have been removed - nearly all for valve failure (Al-Janabi, 1975ai 
A further problem with reported clinical series is that the 
state of viability of the antibiotic sterilised valves is usually 
not stated or not assessed, although it has frequently been assumed 
that the valves are viable (Gavin et al. 1973a; Kosek et al. 1969). 
The report by Al-Janabi et al. (1972) of pre-implantation 
viability has been questioned by Gavin et al. (1 973) and is in 
conflict with the findings described in Section 5b. Thus, it 
is impossible to be certa.in of pre-implantation viability in the 
small number of reported fresh or antibiotic sterilised valves 
that have been removed. 
It is therefore necessary to make use of an animal model 
as this allows the use of donor tissue of optimal viability a.s 
well as removal for study at any time of normally functioning 
implanted valves. An animal model is particularly appropriate 
to this study, a.s assumptions regarding post-implantation donor 
fibroblast survival are based to a large extent on reports of 
animal work in dogs (Mohri et al. 1967a, 1967b and 1968; 
Buch et al. 9171; Kosek et al. 1969) .• 
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Choice of Animal Species: 
Almost all published experimental work on allograft valve 
transplantation related to dogs (Lam et al. 1952; Beall et al. 
1961; Duran et al. 1965; Mohri et al. 1967a, 1967b and 1968; 
Buch et al. 1971; Hanunon et al. 1974). 
In addition canine heart valve ! tissue has been investigated 
for viability by a number of workers (Reichenbach et al. 1971; 
Angell et al. 1973b; Gavin et al. 1973c). 
The use of the dog for the animal model would therefore 
allow comparison with a considerable amount of published work, 
both in the in vitro and in vivo studies. 
In addition, the ready availability of dogs, both for 
obtaining fresh valve tissue and for experimental surgery, makes 
the dog the clear choice. 
The use of the dog also allowed the operative technique of 
Eguchi and Asano (1968) to be used. This relatively simple 
technique has not been described in other species. 
Isolation of X and Y chromosomes is relatively simple in the 
dog, and the use of a canine model had the aivantage of making 
this investigation simpler than if another species were chosen. 
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Method of Valve Insertion: 
Several studies have demonstrated that the implanted 
allograft must function in order to maintain its structural 
integrity. Lam et al. (1952) were the first to speculate 
that function was important. for continued allograft valve 
integrity as a result of their experience in implantation of 
such valves in the descending aorta of dogs with or without 
aortic regurgitation of the host's aortic valve. Murrey et al • 
(1956), Beall et al. (1961) and Duran et al. (1965) used a 
similar animal model and demonstrated the need for function in 
the allograft valve, as well as the prohibitive mortality for 
this form of implantation. 
The work of Mohri et al. (1967) provided further evidence 
of the need for the allograft valve to be placed in a suitable 
site in the host for continued structural integrity -
subcutaneously implanted valves rapidly evoked an inflammatory 
response and later could not be identified; by contrast, leaflets 
placed in the aortic annulus retained structure and function. 
Buch et al. (1971) used the mitral position for assessing 
changes in allograft leaflets with a frame-mounted valve. This 
requires the use of cardiopulmonary bypass or total circulatory 
arrest with the aid of surface-induced deep hypothermia (Mohri 
et al. 1966a). Although this did not cause a high mortality for 
these workers the techniques are complex, and a similar technique 
in dogs reported by Hammon et al. (1974) carried a 33% mortality. 
An additional disadvantage of this technique is the inevitable 
handling necessary for mounting the valve on a frame, and this has 
led to difficulty in interpretation of subsequent changes (Mohri 
et al. 1967a). 
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A simple operation for placing a semilunar valve in the 
right ventricular outflow tract of a dog was described by Eguchi 
and Asano (1968). 
in Figure 6a-1. 
The principle of this technique is illustrated 
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OPERATIVE TECHNIQUE (Eguchi & Asa no) 
Figure 6a,..1 
Technique of Insertion of a Valve-bearing Conduit into the 
Right Ventricular Outflow Tract of the Dog (Eguchi and Asano, 1968) 
Both the work of Eguchi and Asano (1 968 ) and the work of 
Pierce et al. (1971) demonstrated the low mortality of this 
operation and its relative simplicity. 
This method of valve insertion appeared to offer certain 
advantages for this study, viz: 
1) As the valve would lie within a conduit of its own annulus, 
adjacent artery and myocardium, any trauma to the leaflets 
could be reduced to a minimum during surgical manoeuvres. 
2) Normal physiological conditions could be anticipated, 
particularly if the pulmonary valve were inserted, as the 
conduit would carry the full cardiac output, and the valve 
would lie without distortion, functioning at the pressures 
normal for that valve prior to transplantation. 
3) The use of a valve-bearing conduit would allow considerable 
physical separation of leaflets from host tissue, minimising 
subsequent difficulty with interpretation of histological 
changes due to alterations at the host/graft interface. 
4) The presence of myocardium in the conduit would ensure 
that the clinical situation was simulated closely -
myocardium is inevitably present in aortic valve grafts, 
as well as in conduits used to reconstruct the right 
ventricular outflow (Section 3d). The similarity of the 
completed operation described by Eguchi and Asano (Figure 6a-1) 
and the clinical operation illustrated in Figure 3d-1 is 
striking. 
5) The relative simplicity of the procedure, lack of need for 
cardiopulmonary bypass and demonstrated low mortality were 
further attractive features. 
The in vitro study (Section 5a) had shown that aortic and 
pulmonary valves behave similarly in respect of viability, confirming 
the report of Al-Janabi et al. (1973). Thus it appeared perfectly 
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acceptable to implant the pulmonary valve and use the aortic valve 
from the same donor, handled identically, as a control for pre-
implantation viability testing. 
One potential problem was anticipated with this operation. 
The animals used in the studies of Eguchi and Asano (1968) and 
Pierce et al. (1971) received conduits prepared in formalin or 
mercurial solution; only two dogs received fresh grafts. It 
appeared likely that viable antibiotic sterilised conduits would 
show necrosis and possible disruption of the myocardial portion of 
the conduit. It was anticipated that sudden exsanguination in some 
animals would occur, and for this reason short-term implantation 
was not planned until the number of 'inadvertent' short-term 
survivors was apparent. 
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Choice of Implantation Period: 
In clinical practice the main concern is with long-tenn 
structural integrity and function of the allograft heart valve. 
However, this has been well shown to be influenced by preparation 
techniques before implantation (Angell et al. 1973a; Ross, 1975), 
and it has been postulated that implantation of valves which have 
living fibroblasts in the leaflets will allow continued repair and 
restructuring of the implanted valves (Angell et al . 1973a; 
Al-Janabi, 1975a; Hammon et al. 1974). 
Evidence for continued survival of donor fibroblasts within 
the implanted allograft valve leaflet is conflicting. Mohri 
et al. (1967a, 1967b and 1968) . Buch et al. (1 971) and Kosek et 
al. (1 969 ) have demonstrated survival of donor fibroblasts in such 
valves for up to 5 years, and furthermore, that donor cells actively 
synthesise collagen (Angell et al. 1973a). On the other hand, the 
experimental studies of Duran et al. (1 965) and Duran and Whitehead 
(1966) showed rapid loss of donor leaflet cells. Gavin et al. 
(1973a and 1973b) reported total loss of leaflet cellularity within 
as short a time as 40 days in human allograft valves. 
Thus it appeared likely that the answer to the problem of 
whether donor fibroblast viability was retained following 
implantation could be assessed within a short time of implantation. 
Indeed, in view of the conflicting opinions regarding leaflet fibro-
blast origin (Gavin et al . 1973a) it appeared to be advantageous to 
look at the implanted leaflet within a relatively short period after 
implantation to reduce the possibility of ingrowth of host 
fibroblasts which may be a source of confusion in the interpretation 
of findings. 
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Initial studies confirmed that by 8 weeks the changes in the 
implanted leaflets were clear-cut (see Section 6c) and it was 
therefore decided to use an implantation period of 8 weeks, but also 
to look at valves early after implantation (the anticipated muscle 
disruption in some animals qccurred at about one week and provided 
some of the 'short-term' implanted valves), and in two cases an 
intermediate period of 4 weeks was chosen to illustrate the rate of 
change in the leaflets. 
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6b :METHODS USED IN ANIMAL STUDY 
Preparation of Donor Valve: 
Healthy foxhounds, between 20 and 24 Kg in weight, were used 
as donor animals. 
These donor dogs were selected from animals used for acute 
(non-survival) experimental.surgery at the Wellcome Surgical 
Research Institute. 
Pulmonary and aortic valves were removed under sterile 
conditions immediately after sacrifice of the donor animal. The 
pulmonary valve was removed within a conduit consisting of a cuff 
of right ventricular outflow tract muscle and the main pulmonary 
artery, including its bifurcation and the origin of the left and 
right branches. Such a conduit is shown in Figure 6b-1. This 
conduit has been everted to demonstrate the pulmonary valve; this 
was not normally done as every effort was made to avoid handling 
the leaflets and inflicting injury on them; the valve was viewed 
within the conduit to confirm its normal appearance. 
Figure 6b-1 
Pulmonary Valve Bearing Conduit (Everted to show valve) 
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Care was taken during dissection to avoid injury to the 
pulmonary valve-bearing conduit and as much muscle as possible was 
trimmed away. This trimming was completed at the stage of valve 
insertion, leaving less muscle than is shown in Figure 6b-1. 
The aortic valve of the same donor animal, together with 
adjacent myocardium, mitral valve and aorta was also dissected 
from the donor heart. 
The pulmonary valve-bearing conduit and the aortic valve 
with its adjacent tissue were placed together in a screw-topped 
glass jar containing 100 ml of freshly mixed Antibiotic-Nutrient 
Medium (Table 5a-1). This was achieved within t hour of death 
of the donor animal. The donor valve specimens were then placed 
in a constant temperature refrigerator at 4°c until required for 
implantation. 
When Viable valves were required the storage period in the 
Antibiotic-Nutrient Medium did not exceed 5 dc3iYs. 
When Non-viable valves were required the storage period in 
Antibiotic-Nutrient Medium exceeded 4 weeks (in practice ranged 
from 33 to 41 dcliYs). 
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Assessments at time of allograft valve insertion: 
1) Confirmation of state of viability of implanted valve: 
The determinant of viability was the length of storage 
time in Antibiotic-Nutrient medium, as described in 
Section 6b (Preparation of donor valve). However, for 
confirmation, the control aortic valve was assessed for 
tissue culture growth once the operation had been corn-
pleted. One leaflet of the control valve was washed 
sequentially in three 10 ml volumes of TC199 to remove 
excess antibiotics. The tissue was then minced and 
explants were placed between coverslips for tissue 
culture as described in Section 5a. In this way it was 
possible to confirm that the control valve was in fact 
either viable or non-viable by tissue culture assessment, 
and by implication, that the identically handled, implanted 
valve was either viable or non-viable, since the similar 
behaviour of aortic and pulmonary valves in respect of 
viability had been shown (Section 5a). 
2) Confirmation of histological normality of implanted valve: 
Histological sections I stained with haematoxylin and eosin, 
were made on the remaining control valve leaflets in the 
manner described in the later section on ··Assessments at 
time of allograft valve removal·: This confirmed the 
normal appearance of the adjacent myocardium and aortic 
wall as well as the leaflet tissue. 
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3) Conf i rmation of normal physiolo gical function of 
implanted valve: 
Prior to insertion of the valve-bearing conduit pressure 
measurements were made proximal and distal to the host 
dog's own pulmonary valve. Following insertion of the 
conduit similar measurements were made to assess whether 
any stenosis or regurgitation was demonstrable in the 
implanted valve. Convincing evidence of normal physio-
logical function was further provided by the 'normal' 
undistorted appearance of the conduit and the presence 
of a clearly palpable closi ng shock over the conduit 
valve. 
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EXplant of viable canine heart va lve leaflet 




Well established tissue culture growth of fibroblasts 
from viable canine heart valve lea£let. 
Mitotic activity visible . 
• ? 
\ 
Insertion of allograft valve into host: 
Healthy foxhounds, weighing between 20 and 24 Kg, were used 
as host animals. As far as possible the weight of donor and 
recipient was matched accurately. 
recipient were of opposites-ex. 
In each case donor and 
The dog was premedicated with Acetyl Promazine one hour before 
intravenous induction of anaesthesia with thiopentone sodium. A 
cuffed endotracheal tube was used for ventilation with a Palmer 
pump, and 50% Oxygen and 50% Nitrous Oxide was given. Inter-
mittent halothane (} - 1i%) and intravenous suxamethonium were 
given as necessary. 
The animal was positioned for left thoracotomy as shown in 
Figure 6b-2. The right femoral artery was cannulated for continuous 
pressure monitoring and for blood sampling for blood gas analysis. 
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Left thoracotomy was performed, dividing as little as possible 
of latissim~s dorso muscle . The left chest was entered through 
the bed of the unresected 5th rib (Figure 6b-3). 
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The pericardium was opened anterior and parallel to the 
phrenic nerve, and an anterior extension of this pericardial 
incision provided wide access to the heart (Figure 6b-4) . 
Lung Phrenic 




After stitching back the opened pericardium and removing 
or)scur:ing (at from the aortic root a view of the heart was 
obtained as shown in Figure 6b-5. Dissection was required along 
the left branch of the pulmonary artery to improve access to the 





Le f t at r i a I 
R i g ht 
ventr i cle 
Figure 6b-5 
A heavy ligature was placed around the main pulmonary artery 
for subsequent ligation - this required careful dissection between 
the aorta and pulmonary artery to a.void injury to the thin-walled 
and delicate pulmonary artery. A light Satinsky vascular clamp 
was applied to the region of the main pulmonary artery bifurcation 
and origin of left branch, and an incision of 2 to 2.5 ems was ma.de 
starting on the left side of the pulmonary artery and extending 
across the bifurcation onto the left branch as shown in Figure 6b-6. 
Blood flow to both lungs continued during this stage of the 
operation - that to the right lung . which remained fully ventilated, 
wa.s unimpaired. The bevelled distal end of the donor pulmonary 
valve-bearing conduit was then anatomosed to the incised host 
vessel using continuous 6/0 Prolene suture material. 
Pulmonary 
ar t e r y 




ar t e r y 
Pulmonary valve 
condu i t 
from dono r 
Figure 6b-6 
With a vascular clamp on the conduit pulmonary artery the 
small Satinsky clamp was removed from the host pulmonary artery 
and haemostasis was confirmed - this rarely required further 
suturing provided that the initial suturing had been meticulous. 
A large Satinsky vascular clamp was then applied to the right 
ventricular out flow tract as shown in Figure 6b-7, enclosing a 
fold of myocardium in a line with the host pulmonary artery and 
extending up to and including the pulmonary annulus, care being 







Clamping of the right ventricular myocardium usually caused 
ventricular tachycardia for 1 to 2 minutes, with a fall in blood 
pressure from the usual 110 to 160 mm Hg to about 70 mm Hg, but 
later use of a bolus of intravenous lignocaine (20mg) reduced this 
period considerably. Normal rhythm invariably returned, a...~d once 
the heart had recovered from the application of the clamp the right 
ventricle was incised for 4 t o 4.5 ems. A strip of Teflon was 
used to buttress the suture line on both conduit and host myo-
cardium. Continuous 2/0 Prolene was used to anastomose the 
trimmed proximal end of the conduit to the host right ventricular 
outflow. 
Following completion of the proximal anastomosis and removal 
of the Satinsky clamp the host pulmonary artery was ligated. This 
forced all the right ventricular output through the conduit and the 
conduit assumed a very satisfactory position without obvious dis-
tort ion. Closure of the grafted valve was readily palpable. 








valve condui t 
in place 
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Pressure measurements were made to confirm satisfactory 
function of the implanted valve, and similar measurements obtained 
prior to i nsert ion of the graft were avai l abl e for a control in 
each case. 
The pericardium was not closed. After confirmation of 
haemostasis the thoracotomy was closed with a single Argyle tube 
for chest drainage . This tube was removed as soon as blood 
drainage ceased - usually within 1 - 2 hours. 
Recovery from this procedure was rapid. The dog was conscious 
within a few minutes of discontinuing anaesthesia. Once the chest 
tube had been removed the dog was returneJ to the kennel. Within 
4 - 6 hours most dogs were able to get up on their feet, a.~d by 
next day they were drinking and eating and able to walk about. 
Streptomycin and Penicillin (Streptopen 2 ml) were given 
twice daily for 5 days. Omnopon was used for analgesia during the 
first night, but no other drugs were given. A blood transfusion 
was given to two dogs in which post-operative blood loss exceeded 
200 ml. 
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Ass essment s at t ime of allo gr aft valve r emoval: 
1) Ass essment of function of implant ed allograft valve: 
At elective removal of the implanted allograft valve the l eft 
thoracotomy was reopened in the anaesthetised animal. Pressure 
measurements were made proximal and distal to the implanted 
valve for comparison with the record obtained under identical 
conditions at the time of valve insertion. 
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Further assessment of the functional state was more impressively 
obtained by direct visual inspection of the valve from above 
once the animal had been sacrificed and the conduit pulmonary 
artery had been opened. 
2) Assessment of structural state of implanted allograft valve: 
The conduit was opened, the incision being placed through a 
commissure to avoid damage to the valve leaflets. The 
appearances of the anastomotic lines, myocardium, pulmonary 
artery and valve leaflets of the conduit were noted, with 
particular attention to the size, thickness, integrity and 
mobility of the leaflets, and the presence of any thrombus 
within the conduit. A single photograph was taken of the 
opened conduit, care being taken to avoid contamination of the 
tissues and handling of the leaflets. The 35 nun colour slide 
thus obtained, while not of optimal quality because of the 
restraints on the photographer in the interests of maintaining 
sterility, was available as a permanent record of the valve's 
appearance. A print of such a slide again loses further in 
quality, but an example is shown in Figure 6b-9. 
Figure 6b-9 
Excised heart showing opened allogra.ft conduit 
Once a single leaflet had. been removed under sterile 
\ 
conditions for tissue culture another representative leaflet 
was removed in a block of adjacent myocardium and pulmonary 
artery and was mounted on a cork square in a perspex container 
containing 0.9% saline solution. This allowed a better quality 
photograph of a leaflet to be made with the leaflet in a more 
natural position. The container used for this purpose is shown 
in Figure 6b-10. A control pulmonary valve leaflet from a 
normal dog of same size was similarly photographed. 
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Figure 6b-10 
Further information regarding the structural state of the 
implanted leaflets was available from the histological slides. 
The third leaflet of the valve was excised at its base. 
This required care and. judgement, particularly when the leaflet was 
very shrunken and thickened, as defining the base of the leaflet 
was not always easy. The excised leaflet was then laici carefully 
onto a glass slide and its outline was drawn onto the under-surface 
of the glass slide to allow subsequent measurement of surface area. 
A control pulmonary valve leaflet from a dog of same weight was 
measured in identical fashion. 
3) Assessment of microscopic appearance of implanted allograft 
valve: 
The excised leaflet, together with adjacent myocardium and 
pulmonary artery, which was used for the photograph in the 
A /. 5 1,.., 
perspex container was used for preparation of standard 
histological sections through the middle of the leaflet. 
The tissue was placed in formol corrosive for fixation and 
hardening for one week. Sections were then cut with a 
razor knife through the middle of the leaflet as shown in 
Figure 6b-11, dehydrated in alcohol and embedded in paraffin 
wax. Sections of uniform 5 micron thickness were cut and 
stained with Haematoxylin and eosin, elastic, trichrome and 














Preparation of histological sections 
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4) Assessment of tissue culture growth of implanted 
allograft valve: 
Half of the leaflet that had been removed under sterile 
conditions from the opened conduit was minced with scissors 
and explants were placed between plastic coverslips for 
tissue culture in TC199. with 301b foetal bovine serum with 
added glutamine as described in section 5a. 
5) Assessment of origin of cells grown in tissue culture: 
The remaining half of the leaflet removed under sterile 
conditions from the opened conduit was finely cut up with 
scissors under sterile conditions in Waymouth medium with 
20% foetal calf serum and added glutamine 2mll1. The explants 
were transferred between glass coverslips into Leighton tubes 
(one explant per tube) containing the same tissue culture 
medium for incubation at 37°c. This study was done 
independantly of that referred to in the preceding paragraph 
(4) at the Department of Animal Reproduction of the University 
of Glasgow Vetinary School. 
Once a confluent sheet of fibroblast growth had become 
established colchicine was added (0.1 ml of Biccult Colchicine 
25 ugm/ml in 2 ml of W~ymouth medium). Colchicine arrests 
mitosis at metaphase (Tjio and Levan, 1956; Ford et al. 1958). 
After a further 12 hours of incubation at 37°c the coverslips 
were removed from the Leighton tubes and separated in 0.2% 
potassium chloride in water for} hour (this causes cells to 
swell and disperses the chromosomes); then fixed; overnight 
in 3: 1 Methyl alcohol : acetic acid at 4°c. The coverslips 
were then dried and stained with Giemsa stain. 
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Photomicrographs were made of cells with visible 
chromosomes. The chromosomes were then arranged as shown 
in Figure 6b-12. 
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Figure 6b-12 
Chromosomes of a cell grown in tissue culture 





Identification of the X and Y chromosomes was relatively 






isolated. from a cell grown in tissue culture of an allo graft 
heart valve leaflet after 8 weeks implantation. The 39th pair 
of chromosomes are readily identifiable as an X and a Y, showi ng 




6) Assessment of protein and collagen synthesis 
by the implanted allograft heart valve: 
The leaflet that was used for measurement of surface area 
on a glass slide was next taken to the Research Laboratory 
of the Glasgow Royal Infirmary for immediate assessment of 
protein and collagen synthetic activity using the method 
described in Section 5a. The experimental dog's own 
pulmonary valve was used as a control for this investigation. 
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Figure 6b-13 surrunarises the assessments at time of allograft 










Protein and Collagen synthesis 
Figure 6b-13 
All these assessments were made for each of the 8 week implanted 
valves. Some of the one week implanted valves, were obtained 
following disruption of the conduit myocardium; in these cases 
bacteriological smears were taken for culture from within the 
conduit and around the perforated area to exclude the presence of 
infection. In these cases it was not possible to assess protein 






6c RESULTS OF ANIMAL STUDY 
30 dogs were operated on for insertion of an allograft 
pulmonary valve as described. in Section 6b. 
Early in the series two operative deaths occurred. (dogs 
number 2 and 8) due to a combination of operative blood loss from 
the distal anastomosist hypotension as a result of excessive 
halothane administration compounded by blood loss, and intractable 
ventricular fibrillation following intracardiac adrenaline 
administration. Greater appreciation of the hypotensive effect 
of halothane as well as its tendency to induce myocardial 
irritability, well demonstrated in this series, led to reduction 
in the concentration of halothane used and the addition of inter-
mittent suxamethonium, with improvement in the arterial blood 
pressure maintained throughout the operation. 
The operation usually took between 2 and 2} hours from 
start to finish, and the proximal and distal anastomoses took 
20 to 25 minutes each. Continued steady blood loss in two dogs 
from the intercostal tube necessitated blood transfusion of 
300 ml in each case, but in no other case was blood transfusion 
required. 
With the exception of the technical difficulties which led 
to the death of the two dogs already referred to the operations 
were remarkably uneventful and recovery was smooth, prompt and. 
without incident in all cases. 
No evidence of infection was detected. in any of the dogs. 
0 Most had a temperature of 103 - 104 F for 2 to 3 days a..~d this 
gradually settled to 101°F (normal for these dogs) without any 
evidence of pulmonary or wound infection. 
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One of the animals developed progressive abdominal swelling 
following operation. This was soon realised to be due to pregnancy, 
confirmed by abdominal X-ray, and 4 weeks after surgery 11 puppies 
were born uneventfully. 5 days later the animal became unwell, 
with tachycardia, anaemia, pleural effusions, pulmonary congestion, 
ascites, and paroxysmal ven?ricular tachycardia on electrocardio-
graphy. Treatment by suppression of lactation and procainamide 
250 mg 6 hourly was followed by full recovery within 5 days. 
Besides keeping the animal nursing staff busy with hand weaning, 
the incident did demonstrate that the operation was well tolerated 
and. did not impair cardiac output to a clinically detectable degree 
during pregnancy and parturition. The stress of lactation may 
have precipitated cardiac failure due to the fact that this 
particular dog had a viable allograft valve, which suffered severe 
shrinkage and became incompetent. 
Conduit Disruption 
As mentioned in Section 6a (Method of valve insertion) it 
was anticipated that disruption of necrotic conduit myocardium might 
occur. This did in fact occur in 7 animals (5 with viable and 2 
with non-viable grafts) between 5 and 7 days. In each instance 
death was sudden and unexpected. Autopsy showed the chest to be 
full of blood which had escaped. from a perforation of the conduit 
myocardium close to the proximal suture line. The entire conduit 
myocardium was soft and friable. Bacteriological examination 
confirmed that this area of the conduit was sterile. 
Conduit disruption appeared to be an inherent hazard of this 
operation, but it caused no difficulty apart from adding an element 
of unpredictability to the supply of 'short-term' implanted valves. 
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ALLOGRAFT VALVE I MPLANTATION 
TIME IMPLANTED VIABLE VALVES NON-VIABLE VALVES 
Dog's Name Storage Do~'s Name Stora~e 
Cody 1 day Gupta 35 dey 
'Short-term' Bobby 1 
Dinty 33 
Iris 5 Berta 35 5 - 7 deys Angie 2 Chuck 36 
Hank 5 Limus 41 
Polly 3 Gyp 37 
'Intermediate' Liam 5 
4 weeks Kobie 3 
Cyrus 1 Cindy 37 
Jacobia 5 Simba 34 
Dumas 1 Alta 34 
'Long-term' Zachary 1 Quita 40 
8 weeks Milne 5 Hilda 40 




Figure 6c-1 shows details of the numbers of dogs for each 
category of valve. 'Storage' refers to the number of deys the 
grafted valve had been kept in Antibiotic-Nutrient medium, and 
hence indicates whether the valve was viable or non-viable (see 
Section 6b - Assessments at time of allograft valve insertion ( 1) ). 
From the 28 operative survivors the following allograft valves 
were available for study: 
6 viable valves implanted for 5 - 7 deys 
2 viable valves implanted for 4 weeks 
8 viable valves implanted for 8 weeks 
6 non-viable valves implanted for 5 - 7 days 
6 non-viable valves i mplanted for 8 weeks 
An 'intermediate' implantation period for t he non-viabl e 
valves was not cons idered necessary i n view of the similarity of 
histological changes at 1 week and at 8 weeks in t hese valves. 
6c RESUL'rS OB' ANIMAL STUDY 
Assessments at time of allograft valve insertion 
1) Confirmation of state of viability of implanted valve: 
14 of the 16 control aortic 'viable' valves grew promptly 
in tissue culture , the rate of growth being similar to that for 
fresh canine valves as shown in Section 5a, thus confirming the 
viability of the implanted valves in this 'viable' group. 
One of the 16 control aortic 'viable' valves showed initial 
growth in tissue culture, which ceased after 2 days; and another 
one of the 16 failed to show evidence of tissue culture growth. 
The explanation of this failure to confirm the expected viability 
in these valves is not clear - one valve had been stored for 1 day; 
the other for 5 days and it is likely that the failure of tissue 
culture growth was due to a technical problem with the technique of 
tissue culture, rather than impairment of viability of the tissue. 
One of these valves was used for ' short-term' implantation; the 
other for 'long-term' implantation. The subsequent leaflet changes 
were in keeping withihe others in their respective groups, lending 
support to the assumption that the valves were in fact viable. 
None of the 12 'non-viable' valves showed any evidence of 
tissue culture growth. This was in keeping with the findings of 
Section 5a where none of the 40 valves stored in Antibiotic-Nutrient 
medium for more than 4 weeks showed tissue culture growth. 
2) Confirmation of histological normality of implanted valve: 
Histologically I the control aortic valve leaflet , the control 
adjacent myocardium and aorta, showed a normal appearance in each 
instance, although evidence of mild oedema of the leaflet was present 
in the 'non-viable' group as illustrated later in this section. 
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3) Confirmation of normal physiological function of implanted 
valve: 
In each case the conduit assumed a very satisfactory position 
once the anastomoses were completed.and the host main pulmonary 
artery had been ligated. 
An easily palpable closing shock was present over the conduit 
valve in each case. 
In three dogs angio-cardiographic confirmation of the 
satisfactor-~ anatomical position of the implanted conduit was 
obtained; the procedure was not considered necessary in the 
remaining do gs. The quality of the angiography was not optimal 
because of the unsuitable radiological facilities available for 
angiocardiography. However, in the angiocardiograms that were 
obtained the conduit 18iY in a very satisfactory position, not being 
obviously different from the normal right ventricular outflow tract 
before implantation of the conduit. 
Pressure measurements were made as shown in Figure 6c-2 before 
and after implantation of the conduit. 
typical tracings. 
Figures 6c-2 and 6c-3 show 
Right ventricular systolic pressure ranged between 20 a.nd 40 
mm.Hg. in 24 of the 28 surviving dogs prior to implantation cf the 
conduit. In 4 dogs the right ventricular systolic pressure was 
lower, and this was almost certainly due to excessive halothane 
administration, which was noted to have a marked hypotensive effect 
in this series. 
A gradient was commonly present across the normal host 
pulmonary valve prior to im;er·i; ion of the cond..ui t, and measured. 
between 5 and 10 mm.Hg. in 18 of the 28 dogs. 
Although pulmonary arterial diastolic pressure is nonnally 
low in the dog clear evidence of a difference between pulmonary 
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arterial diastolic pressure and right ventricular end diastolic 
pressure was always present, both in the host animal prior to 
implantation, and in the conduit, giving clear evidence of function 
of the implanted conduit valve in each instance (Figures 6c-2 and 
6c-3). 
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Angiographic appearance of dog's right ventricular outflow 
and pulmonary artery - prior to insertion of conduit 
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Angiographic appearance of sn.me dog - after insertion of 
conduit - showing satisfactory anatomical osition_of conduit 
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DINTY 24 . 6 . 75 At t hor acotol!\Y - bef or e implantation of conduit 
Pressure scale O - 50 mm Hg. Pap er speed 10 mni/ sec 
Pressures in Host Ri ght Ventric l e (RV) an:l Host F\.llmona ry Artery (PA) 
; 
Pressure measurements 
at Host PA 
Conduit PA 
implantation Conduit RV 
HOS t RV 
of conduit 
I 
T.lTi?l'Y 24, . 6 . 75 At t hor.'.' C~J torzy - ::,f t er i 0 'rol en";. n.tion of cordui t 
Pre~sure scr:::;..C' 0 - 50 rrcr. Hg Pal,c r s _p::ed 25 mm/sec 
Pressures in :.Iost Ri g:n Ve:1tricle ( S:V), Con-~uit Hight Vei1tricle ( 1W), 






I RIS 10 . 6 .75 At t hor acot orey - b efore i mpl 2ntation of' conduit 
Hos t R V 26/0 Host P A 20/7 _ 
Nor '."lal gr ad ient over pul:!10n 2,riJ valve; normal Tub 1ona ry artery d i a s tolic 
pressure 
--·-- - - _____ _; ------ -- - ·---
-- -- __ __.j -- ------ -- -
-
' 
• ---r---~ . -- - ----~-----· --~-:c:--·· ~- --- ... - - ---- ·--. . -~ - - -· 
I RIS 10. 6 . 7 5 At thor.sc ot orey - d' t e r i mnl r' n t 2, t ion of c onfiu i t 
~RV 4-1/0 c o.:iduit R V 3 8/ 0 Conduit PA 32/ 9 Host ? A 17/ 9 
nor mal gr ar[ j_ c~n t over coDd.uit v s l ve ; n or mal puln,0113.ry art::r:r d if.s tolic 
pressure 
Good Haemodynamic Function of Conduit 
Figure 6c-3 
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6c RESULTS OF' ANIMAL STUDY 
Assessments at time of allograft valve removal. 
21 of the 28 implanted allograft valves were removed at 
elective operation and the assessments described in Section 6b 
were made. 
7 of the 28 (all 'short-term' valves) were removed at autopsy 
following conduit disruption. Pressure measurements and assessment 
of protein and collagen synthesis were not possible in these. 
1) Assessment of function of implanted allograft valve: 
All dogs coming to elective removal of their allograft valve 
had remained well and active during the period of valve implantation, 
with the sole exception of the one animal referred to earlier which 
developed transient heart failure during lactation. 
In about half this group a soft systolic murmur was audible. 
over the chest, but a diastolic murmur was not audible in any of 
the dogs. 
At re-operation, the implanted conduit was seen to lie in a 
very satisfactory position. There were invariably light ad..hesions 
between it and the overlying lung. 
Pressure measurements made proximal and distal to the conduit 
valve (as described in Section 6c 'Assessments at time of allogra.ft 










Normal .!:' .J.. i. UDCul.On 
Normal fU11ctio:1 




Figure 6c-4 shows the pressure records obtained from 
ZACHARY at the time of implantation of a viable valve. There is 
good function of the conduit valve shown by the absence of sig-
nificant gradient over the valve, and well maintained pulmo_nary 
arterial diastolic pressure. Figure 6c-5 shows the striking 
difference between the record at implantation and the record 
obt ained 8 weeks later. Right ventricular end-diastolic pressure 
is elevated and pulmonary arterial diastolic pressure is equal to 
right ventricular end-diastolic pressure - indicating right 
ventricular failure and pulmonary regurgitation. 
By contrast, Figure 6c-6 shows the pressures recorded in 
CINDY at the time of implantation of a non-viable valve. After 
8 weeks of implantation the pressure record obtained at re-operation 
shows that conduit valve function is retained. 
The finding of retained function in the non-viable valves 
after 8 weeks of implantation was constant one. Figures 6c-7 to 
6c-10 show clear haemodynamic evidence of retained function in 
non-viable allograft valves after 8 weeks of implantation. 
In only one of the 8 viable valves implanted for 8 weeks was 
a normal pressure record obtained at re-operation; and in this dog 
-·~ne implanted valve had a normal appearance. 
The remaining 7 of the 8 viable valves showed haemodynamic 
evidence of virtually total lo ss of valve function at 8 weeks. 
In each instance there was clear evidence of normal valve function 
at the time of implantation of the conduit (Fig~res 6c-11 io 
6c-14). 
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ZACfLA.~Y ll. L.1c. 75 At thore.c otomy - before implanta tion of conduit 
Host R V 30/ 6 Host PA 25/ 18 
Norm?.l gr adiei1.t over host pulmona:ry valve 
Nor-al pulmonary art ery d i ast olic pressure 
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ZAC:3..fi.FIT 11. ·±. 75 At thor2.coto111Y 
Host H V Z3/ 9 Conduit RV 30/9 
. -
5 0-~ •f,'·..,.."il'.-r•~-. . 
·,, 1z ACHARY ·.~: ......... --'----- . . ,' ____ . ___ . ·--' .. ·r ;-?~ . . 
· condu it ' 40-· 
. !. __ '1.-· .. -
,, ~--: 
10 --- .. -.. -I 
- d ' ter i r:ipl,·n t e. tion of conduit 
- · ----h---· 
ZACHARi 11. -. 75 
Conduit FA :50/ 20 
ht t i1orecoto 0ny - : _( ter i ::rpl an.t r; tion oo:' conduit 
:rost P A 28/ li.., 
No gr a dieilt :,vcr c c:;,Ju it w,lvc; c:L(;· · ev i cl,:..nce o:c c u:1"·,_.j_L valve 
Cl) 11.Je t Ci lC e 
Good Conduit Funct on 
Figure 6c-4 
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ZAOF...ARY 11. 4 . 75 
Conduit RV 30/10 
Clear evidence of 
Viab l e Va lve at time of i mphntation 
Conduit P A 2 8/ 20 
c onduit v alve compe t ence 
Viable Valve No rm a I Function at implantation 
ZACHARY 5.6.75 Same v a lve Bfter 8 weeks i mpl antation 
Con·luit R V 28/ J2 Conduit P A 25/ J2 
No evic1e ice of co11dui t val ve c ompet enc e 
Same Valve Loss of Funct on after 
Figure 6c-5 
8 wee ks 
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CTIIDY 17 .4. 75 
Host RV 25/0 
At thoracotorqy 
Host PA 15/10 
before i mpl antation of conduit 
Norma l gradient over va lve 
Normal puL>rona ry artery d iastolic pressure 
CINDY 17 .4-. 75 At t horacoton:or - after i mpl8ntat ion of conduit 
Host R V 38/0 5 Conduit R V 35/ 2 Conduit PA 25/15 Host P A 21/13 
Normal gradient over conduit v a lve ; normal PA diastolic pressure 
NON-VIABLE VALVE 
CINDY 12 .6. 75 At thor acotomy for remova l of c onduit 8 weeks l a ter 
~ost RV 50/ 0 Conduit RV 45/ 0 Conduit PA 29/ 12 Hos t P A 17/13 
Normal gr ad ient over c ona.uit valve; norni.al P A d i F.stolic :rr essure 
Normal Function Retained in Non-Viable Valve 
Figure 6c-6 
AIJrA 22 . 5 .75 
Hos t RV 24/ 0 
At thoracoto1ey - bef:ore i mpl
2ntation of c onduit 
Hos t PA 17/6 Normal gr adi
ent over valve 
Normal pulmonary ~rt2ry d ias
tolic pressure 
AlirA 22 .5.75 At t horacotorr
~ - af ter i mplan tat i on of c o
nduit 
Host RV 24/ 0 Conduit RV 26
/ 0 Conduit PA 23/ 9 Host P
A 16/9 
Norrr .. a l gr adi ent over c onduit
 7 2.1 ve; normal P A d i e.stolic
 pressur e 
. 
--------· .. ·-----
------· - ----· ---·-- -
------- _·- -. : -~--~--j 
ALTA 15 . 7. 75 At thor2co t on
zy- for r e11;0·,r."'~l cf co:1·.'J-'.i t L "
eeks l a tc:r 
Condvit R V 32/ 3 Conci.o:i t P 
A 25/ 12 
Norn12.l ,:i:r adieEt over c -.:,fr ··:~i t 
vnl'.-t·· ; nor mal F A diast olic 
p re ssur e 
Normal Function Retained in Non-Viable Va
lve 
IC• II t' .0 6 -7 
14 
QUI TA 10.6.75 






V 27/ 0 
At thoracotomy - before i mplantation of conduit 
Host PA 10/ 6 Norw.al gr aaient over valve 
Normal pul.'1lonary artery diastolic pressure 
At thoracotomy 
conduit RV 26/0 
J,---· 
No gradient over conduit va lve ; 
aft er impll'.ntat ion of' conduit 
Conduit P A 27 / 8 Host P A 21/8 
normal P A diastolic pressure 
QUI'?.-1. 5 . e. 7 5 ~·~t 
Cojduit R V 17 / 2 
No :Cc.a ient ~,ver 
NON- .J H.ELE VALVE 
t horac ::i to:r1_y fc1· :,'err.,:Yv· J. of cu.-··.:iu i t 
Conduit I' A b/5 
,>:>.1 \uit ve.J v e: , norn.2.~. :2 A c:i.i ."' ~:;to lie 
8 vteeks later 
1:essur 
Normal Function Reta ned in Non-Viable Valve 
Figure 6c-8 
HILDA 10. 9.75 Non-viable Valve implanted 8 weeks 
Pressure scale O - 50 mm Hg 
Paper Speed 10 mm/sec 
Pr~ssure measured in Conduit Right Ventricle (RV) 
and Conduit Iulmonary Artery (PA ) 
Figure 6c -9 
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Normal Function Retained in Non-Viable Valve 
SI MBA 12.6 .75 Non-viable Valve i mplanted 8 weeks 
. Pressure sca l e O - 100 mm Hg 
Paper Speed 10 mm/ sec 
Pressure measured in Eost Right Ventricle (R V) 
Conduit Right Ventricle (R V) 
and Conduit Pt.1lmona.::y Artery (P A) 
Figure 6 c - 1 O 
--· --- ·--·- ·---- -····- -- --· - . . ..... ·- --·-· ---- --
NII.NE 
c onduit 
11. 4 . 75 Viable v 8 lve at time 
R V 24/ 0 Conduit PA 23/ 7 
of i mpl en ta.t ion 
Conduit valve i s compet ent . 
Vi able Va Ive No rm a I Function 
1 ]1 I...1\JE 5. 6 . 75 Viable v a l ve i mpb11t ed 8 ,,reeks 




Condu it ,r lve is now i r1c 0~r; ·c t ent c..:d hPs 2. ::;r ai~_e,n over i t. 
Same Valve Loss of Fun ct on after 8 we e ks 
figure 6 C - 11 
- - -------,--- - ------- -- -- -
PEARL 24. 7 .75 Viable valve at time of i mplantation 
Pressure scal e O - 50 mm Hg P~per Speed 25 mmjsec 
Pressure mee.sured in :Iost Right ventricle (R V), 
concl..uit Ri~ht ventric le , Conduit B.llnioncc.r.f Arte:cy (PA) 
and Rost Pulmon&ry J,rtery 
conciu.it RV 30/3 Conduit PA 27/21 
Con5 ..ui t valve co:npetent. 
Viable Valve - Normal Function at implantation 
PEAP.L 10. 9 . 75 Viabl e Va.lve implanted 8 weeks 
Pressure scale O - 50 Ill~ Hg 
Paper Speed 10 nun/ sec 
Pressure measured in Conduit Right Ventricle (RV) 
ancl conduit Pulmonary Artery (PA) 
Same Valve - Loss of Function after 8 weeks 
Figure 6c-12 
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Viable Valve - Normal Function at implantation 
-·--·· - :-·· -- ·- - - - - -- . ---
Dwnas 10 . 4 . 75 Viable va lve at time of i mplrntation 
?ressu r e scale O - 50 m"71 Hs To.per Speed 25 rmnjsec 
Pressur e 1.1ec.sured i n Host Right Ventri cle (R V), Conduit 
Ri 6ht Ventricle , Conduit Pulmona ry A1°tery (P A) ?nd. 
Host Tu.l rnonary Artery. 
Conduit R V 33/ 3 c onduit P A 25/11 
Normal puL"!iona.ry valve r;r a3-i ent; conpeteI1t v e.lv e 
DU11~ S 5 . 6 .75 Viable Vr: lve i mplanted 8iveeks 
Pressure SC [cle O - 50 nEn Hg 
Fa1)er Speel 10 :rrm,jsec 
P-.cessure m0a su red i n Condu i t Right Ventri cle ( ~~ V) 
and Co 1clui t :t?c.J..conc r:y Artery (P A) 
Same Valve - Loss of Function after 8 wee ks 
Figure 6 c-13 
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JACOBIA 29 •. 5 . 75 Viable valve impLmted 8 weeks 
Conduit R V 55/ 0 Conduit P A 24/ 4 
Loss of Function in Viable Valve 
Figure 6 c-14 
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2) Assessment of structural state of implanted allograft valve: 
' Viable ' valves implanted for 5 - 7 days ( 1 short-term') 
In this group of 6 all opened conduits appeared little changed 
from the time of their implantation. In one case there was a thin 
layer of thrombus on the myocardium of the conduit and in one sinus 
of the valve - the leaflets looking mildly reddened; but in all other 
cases the leaflets appeared normal. The anastomotic suture lines 
were satisfactory and the opening from the host to donor right ventricle 
and donor to host pulmonary artery was wide and unobstructed in each 
case. The myocardium of the conduit was very soft, and had in fact 
disrupted in 5 of the 6 in this group. 
'Viable ' valves implanted for 4 weeks ('intermediate') 
Tne two conduits in this group appeared virtually normal, but 
the myocardium of the conduit was noticably thinner and paler than 
the adjacent host myocardium , and the valve leaflets were thickened 
and opaque. The valves appeared to be haemodynamically competent 
and there was no appreciabl e shrinkage of the leaflets of the valves . 
' Viable ' valves implanted for 8 weeks ('long-term ' ) 
7 of the 8 opened conduits in this group showed gross shrinkage 
and retraction of the valve leaflets , such that valve competence was 
impossible ( confirming the haemodynamic findings ). The valve 
annulus was noticably shrunken in these , and in 4 the proximal 
anastomosis seemed to have shrunk , although these changes did not 
appear severe enough to constitute haemodynamic obstructions. There 
was adherent thrombus present in 3 sinuses of one valve, and one 
sinus of another~ The striking changes, however, were in the 
leaflets, which W8re grossly shrunken and deformed to the extent of 
being totally functionless. 
Inexplicably, one of the 8 'viable' valves showed no shrinkage 
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or thickening and the valve was competent. There is no reason to 
doubt the viability of the implanted valve - it had been stored for 
only 1 day, and its control aortic valve showed prompt growth in 
tissue culture. 
'Non-viable' valves implanted for 5 - 7 days ('short-term') 
The appearances of the opened conduits in this group were the 
same as for the 'viable - short-term group'. 2 of the 6 in this 
group had disrupted the soft conduit myocardium. Thrombus was 
present in 1 sinus of the valves of 2 conduits. 
'Non-viable' valves implanted for 8 weeks ( 'long-term') 
All 6 opened conduits in this group showed valve leaflets of 
normal dimensions, that were clearly capable of normal function. 
The conduit muscle was pale and tough, as in the case of the 'viable' 
valves at the same stage, but the contrast in the appearance of the 
valve leaflets was striking. The anastomoses and the valve annulus 
appeared to be of normal dimensions. 
in one sinus of each of two valves. 
Adherent thrombus was present 
Figure 6c-15 shows the appearance of the opened conduit with 
a 'viable' valve after 8 weeks of implantation. 
retraction of the valve leaflets can be seen. 
The shrinkage and 
Figure 6c-16 shows an opened conduit with a 'non-viable' valve 
after 8 weeks of implantation. The leaflets are of normal size, 
but this is not clearly shown because of the need to avoid wiping 
or manipulating the leaflets in order to conserve sterility a...~d 
avoid histological injury. 
Figures 6c-17 to 6c-28 illustrate the cha...~ges and the striking 
differences between the ' viable' and 'non-viable' valves after 
8 weeks of implantation more cle2.rly. Figure 6c-19 is an example 
of a normal control canine pulmonary valve leaflet suspended in 
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Conduit Myocard i um 
Figure Ge - 15 
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Non-vic,.ble Va lve 
l<'i_;ure 6c - 16 
Figure 6c - i7 
Conduit everted to shew, v 2-lve - prior to 
trimining of myocc..r dium for i mplantation. 
Fi::{Urc 6c - 18 




Figure 6c - 19 
Control F r esh Pulmonary Leaf'let 
Vfa.ble Leoaf l et af te:r 3 v:ee',<- s i mplant at ion 
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Fi6ru.re 6c - 25 
Control Fresh Iulrnonery Leaf let 
Fi£,ure Ge - 26 
Non-viable Leaf let a£· t e r 8 v:eel-:s impl e..nt&.tion 
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Figure 6c - 27 
Cont r ol Fresh I-UL~onar"J Leaflet 
Fizure 6c - 28 
Non-viable l e,,flct 1.:i'ter 8 \':eeb; i r:rpL:n t2.tio::1 
artery wall and show the delicate, thin, white, translucent nature 
of the normal 1 eafl et. The I viable' valves show shrinkage of the 
annulus (the leaflet commissures are closer together than in the 
controls from dogs of same weight), and the leaflet tissue ·is 
shrunken and retracted. The 'non-viable' leaflets are thicker 
and opaque,but of normal size. 
Measurement of valve leaflet area: 
As described in Section 6b one leaflet of each valve was 
measured to assess surface area. The leaflet chosen was the 
posterior one, and this was representative of the whole .valve as 
all three leaflets showed similar changes in each case. As a 
control, the posterior pulmonary leaflet of a dog of same weight 
was chosen. Surface area was measured by drawing the leaflet 
outline onto graph paper. 
As shown in Figure 6c-29 the shrinkage occurring in the 
'viable' valve leaflets after 8 weeks is striking (with the sole 
exception of the valve already mentioned) - the mean surface area 
for this group was 48 sq. mm. ar:dthe controls 114 sq. mm. 
By contrast the mean surface area of the 'non-viable' valve 
lt!aflets was 1·15 sq. mm. and the controls 107 sq. mm. 
These figures clearly demonstrate the shrin.~age of the 'viable' 
leaflets, and the normal size of the 'non-viable' leaflets at 8 
weeks, but they imply a degree of precision that is not entirely 
warranted in view of the difficulty (explained in Section 6b) of 
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"Non-Viable" allograf't valve after 8 weeks implentation 
- showing normal dimensions (H & E x 10) 
"Viable" allograft valve af'ter 8 weeks implantation 
- showing gross shrinkage (H & E x 10) 
0 Non-Viable11 a llogra:ft valve after 8 weeks i mplantation 
- showing normal dimensions (Elastica x 10) 
11 Viable11 allogra:ft valve after 8 weeks i mplantat ion 
- gross shri nkage again evident ( H & E x 10) 
3) Assessment of microscopic appearance of valves 
Normal canine pulmonary valve leaflet: 
The histological appearances of a normal canine pulmonary 
valve leaflet are shown in Figures 6c-30 to 6c-36 . 
All the photographs illustrating histological appearances 
are of sections cut through ~he middle of the leaflets as described 
in Section 6b (see Figure 6b-11). 
The valve leaflet consists of a framework of collagen and 
elastic fibres in a mucopolysaccharide ground substance, bounded 
at the surfaces by an endothelium. Interspersed between the 
fibres, and fairly unifprmly distributed throughout the leaflet, 
are the connective tissue cells or fibrocytes (when young and active, 
or when growing in tissue culture these same cells are known as 
fibroblasts). 
In the sections illustrated the collagen fibres are seen as 
a densely packed and rather convoluted la;yer on the pulmonary 
arterial side of the leaflet (the 'holding face') and a flatter, 
less densely packed layer on the ventricular side of the leaflet 
(the 'deforming face'). The fibrocyte nuclei are typically spindle 
shaped, but depending on the plane of the section through the 
Hucleus ma;y appear round or oval. 
As shown in Figures 6c-31 and 6c-35 -the elastic fibres are 
closely packed on the ventricular side of the leaflet, with a 
particularly dense la;yer just below the endothelium of the 
ventricular surface. A similar, but thinner, la;yer is present on 
the pulmonary arterial side of the leaflet. These subendot 11.el ial 
concentrations of elastic tissue, well seen on the elastic- stained 
slides, identify the outline of the original leaflet and demarcate 
new tissue laid down on the surface after implantation. 
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FIGURE 6c - 30 
Normal c anine pulmon a ry va lve leaf l e t 
The r echnsle sho,;m on the l eaflet defines 




Figure 6c - 31 
Normal canine pulmonary valve leaf let 
Hte 'lo /00 _J 
Figure 6c - 32 
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Figure 6c - 33 
Normal canine pulmonary valve leaflet 
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Figure 6c - 34 
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Figure 6c - 35 





Figure 6c - 36 
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Canine pulmonar.y valve leaflets following sterilisation 
and storage 
After 4 weeks storage in Antibiotic-nutrient medium a.t 4°c 
the leaflets showed some separation of collagen fibres, thought 
to be due to oedema of the leafl ets . 
normal (Figure 6c-37). 
The fibrocytes appear 
After 8 weeks storage in Antibiotic-nutrient medium at 4°c 
the leaflets showed further separation of fibres and some of the 
fibrocytes show early nuclear degeneration (Figure 6c-38). 
Viable leaflets after 5 - 7 dals of implantation 
( 'short term') 
All the leaflets in this group of 6 valves were slightly 
thickened, and considerably more cellular, than the control leaflets 
(Figures 6c-39 to 6c-44). 
The increased cellulari-ty was due to the presence of 
inflammatory cells, mostly macrophages and plasma cells, but 
poly1norphs and red cells were also present. The cellularity 
was most marked near the valve surfaces. Endotheliun1 was not 
visible over most of the leaflets, being obscured or covered by 
inflammatory cells. 
Fibrocytes were identifiable within the leaflets, and their 
appearance was normal. 
The elastic stain (Figure 6c-42) showed that separation of 
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the elastic fibres had occurred, and also that leyers of inflarr.matory 
cells were present on the leaflet surfaces. 
Viable leaflets after 4 weeks of implantation ('intermediate 1 ) 
The leaflets of the 2 valves in this group showed uniform 
changes throughout the leaflets. Considerable thickening was 
present due to the presence of inflammatory cellular tissue on 
both surfaces of the leaflet - approximately doubling the leaflet 
thickness. The cells in this tissue were mainly macrophages, with 
a few polymorphs , lymphocytes and plasma cells . 
The basic architecture of the original valve leaflet was 
fairly well preserved , but the elastic stain showed the elastic 
fibres to be separated. The l eaflet itself showed considerable 
cellularity - due to the presence of macrophages and fibrocytes, 
but also a few polymorphs and lymphocyt es. There were a large 
number of degenerating cells with pyknotic nuclei scattered 
throughout the leaflets • 
.An endothelium was present over the distal 1/3 of the 
ventricular surface of one leaflet, but as it was situated on the 
surface of a leyer of inflammatory tissue laid down on the original 
leaflet it was presumably not the original endothelium of the 
leaflet. 
Figures 6c-45 and 6c-46 show a section of one such leaflet. 
Viable leaflets after 8 weeks of implantation ('long-term') 
The leaflets of 7 of the 8 valves in this group showed 
variable degrees of shrinkage from tip to base of leaflet, with 
slight thickening due to the presence of additional tissue on the 
surfaces ( usually cell-free tissue, but occasionally containing 
plasma cells). 
The leaflets of all 8 valves were essentially cell-free, but 
three showed 'islands' of considerable cellularity causing con-
siderable local thickening. The nodule at the tip of the leaflet 
illustrated in Figures 6c-47 and 60-48 is one such cellular island. 
However ,the vast majority of the leaflet area in the sections 




Figure 6c- 49 , 6c-50 and 6c-51 could well illustrate the 
histological appearance of any of the 8 viable valves at this 
stage. 
Occasional inflrunmatory cells (mostly macrophages) were 
present on the leaflet surface, and endothelium was absent. 
Thus it was clear that the viable leaflets showed an 
increase in cellularity after one week of implantation, largely due 
to the presence of an inflammatory reaction. This was still present 
at 4 weeks, but at this stage there was evidence of considerable 
cell destruction. By 8 weeks the leaflets were virtually devoid 
of cells, the islands of persistent cellularity seen in 3 of the 
8 valves being in no way representative of the bulk of leaflet 
tissue at this stage. 
Non-viable leaflets after 5 7 days of implantation 
('short-term') 
The leaflets of all 6 valves in this group were of normal 
dimensions, with little alteration in basic architecture and 
virtually no inflammatory tissue on the surfaces. 
The leaflets were uniformly devoid of cells, very occasional 
pyknotic nuclie being the only evidence of previous cellu.J.arity. 
Figures 60-55 to 6c-60 show the amorphous, cell-free 
appearance of these leaflets at this time. This contrasts with 
the increased cellularity cf the viable valves at the same period 
of implantation (Figures 6c-41 and 6c-43). 
One of the valves illustrated shows thrombus in the sinus of 
the valve. Endothelium was not present on any leaflet. 
Non--,viable leaflets after 8 weeks of implantation ('long-term') 
The leaflets of all 6 valves in this group were of near 
normal dimensions, slight thickening being present toward the base 
of the leaflets. 
,· 
Figures 6c-61 to 6c-65 illustrate the typical cell-free 
appearance with preservation of basic leaflet architecture seen 
in valves of this group. Endothelium is not present, and there 
is little inflammatory tissue on the leaflet surface. 
Thus, in non-viable leaflets the cells have totally 
disappeared after 1 week of implantation, and the inflammatory 
response present in viable valves at this time is absent. The 
structural damage to the leaflets, evident at 8 weeks in viable 
valves, is not seen in non-viable valves. 
Areas of Cellularit;y in 'long-term r viable valves: 
In view of the fact that persistence of cellularity in 
leaflets of viable donor valves has been reported by M:ohri et al. 
(1967a, 1967b and 19.68); Buch et al. (1971); and Kosek et al. 
(1969) it is of interest to note the presence of cells in small 
-'islands' that were seen in 3 viable leaflets after 8 weeks of 
implantation. 
Figures 6c-65 and 6c-66 show such areas of cellularity at 
the tip of a leaflet; however the totally cell-free nature of the 
rest of the leaflet isSJ.own in Figure 6c-67, and this was the 
appearance of more than 80% of this section. 
Figure 6c-68 shows another example of such a cellular area 
at the tip of a leaflet; Figure 60-69 shows the cell-free nature 
of the majority of this leaflet • . 
The third example of such a cellular area is seen in 
Figure 6c-47. 
Many of the cells in these areas are typical fibrocytesj 
the rest are mononuclear cells with more rounded nuclei which 
could be either macrophages,or the 1dysplastic' fibroblasts 
described by Mohri et al. (1967a) and Angell et al. (1973a). 
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Figure 6c - 37 
After 4 weeks storage in Antibiotic-nutrient medium 
r.: 
Figure 6c - 38 
After 8 weeks storage in Antibiotic-nutrient medium 
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F i gure 6c - 39 
Viable Leai'let i mplanted 1 week ( 'Cody t) 
Figure 6c - 40 
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Viable Leaflet implanted 1 week ( 'Cody 1 ) 
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Figure 6c - 43 
Viable Leaf'let implanted 1 week ('Bobby') 
Figure 6c - 44 
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Vi able Leaf'let implanted 4 weeks ('Liam ') 
Figure 
6c - 45 
Figure 
6c - 46 
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Figure 6c - 47 
Viable- Leaflet implanted 8 weeks ('Dumas ') 
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Figure 6c - 48 
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Figure 6c - 49 
Viable Leaflet implanted 8 weeks ('Dumas ' ) 
r 
Figure 6c - 50 
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Viable Leafle t i mpl an ted 8 weeks ( 'Dumas 1 ) 
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6c - 51 
Figure 
6c - 52 
182 
18 3 
Figure 6c - 53 
Viable Leaflet implanted 8 weeks ('Jacobia') 
Figure 6c - 54 
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Figure 6c - 55 
Non-viable Leaflet implanted 1 week ( 'Dinty') 
"' I oo _J 
Figure 6c - 56 
Figure 6c - 57 
Non-viable Leaflet implanted 1 week ( 'Dinty ') 
Figure 6c - 58 
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Non-viable Leaflet imp l anted. 1 week ( 'Berta ' ) 
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Figure 
6c - 59 
Figure 
6c - .60 
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Fic?,u:ce 6c - 61 
Non- vie_bl e Leaf let i mpl 2nt ed 8 weeks ( 'Alta 1 ) 
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6c - 62 
188 
Non-viable leai'let impl2.I1ted 8 weeks ('Alta. ' ) 
Y. 1+-00 
6c - 63 
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Figure 6c - 64 
Non-viable leaflet implanted 8 weeks ('Alta') 
Figure 6c - 65 
Area of cellularity at tip of viable valve 
leaflet after 8 weeks implantation 
See Figure 6c - 67 
Figure 6c - 66 
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Figure 6c - 67 
Same viable va lve af t e r 8 weeks i mplantat ion as 
shovm in Figures 6c - 65 and 6c - 66 showing a 
c ell-free appearance typ ical of most of ::;ection 
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Figure 6c - 68 
Cellular area at tip of viable 
valve after 8 weeks implantation 
Figure 6c - 69 
Same valve showing a more 
repreBentative cell-free area 
" 1'2..:r _J 
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Changes in the myocardium and pulmonary art ery 
of the conduits 
The myocardium and pulmonary artery of both viable and 
non-viable conduits showed loss of cellularity, particularly 
affecting the myocardium, over large areas by one week, with an 
infiltration of polymorphs, macrophages and plasma cells. 
At 8 weeks large areas of necrotic muscle and pulmonary 
artery were present, and invasion by macrophages and fibroblasts 
with ingrowth of granulation tissue was occurring around the 
periphery of these necrotic areas. Figure 6c-70 shows the 
invasion of necrotic myocardium by granulation tissue in a 
conduit implanted for 8 weeks. 
A surface growth of fibrocytes overlying the myocardial 
portion of the conduit was present in those conduits implanted for 
8 weeks, whether originally viable or non-viable. At this stage 
after implantation, however, the advancing fibrous tissue did not 
reach the base of the leaflets, and did not constitute a host 
fibrous sheath on the leaflets as described by Angell et al. (1973a ) • 
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Figure 6c - 70 
Invasion of necrotic myocardium by granulation 
tissue in a conduit after 8 weeks implantation 
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4) Assessment of tissue culture growth of implanted valves 
Half of one of the leaflets removed under sterile conditions 
from the opened conduits was set up in tissue culture as described 
in Sect ion 5a. 








All 4 examined showed prompt tissue 
culture growth within 5 dcys. 
1 of 2 valves showed tissue culture 
growth within 10 dcys. 
6 of the 8 valves in this group showed 
sluggish growth after about 10 dcys; 
4 of these 6 however ceased growing 
after a further 7 to 10 dcys and died. 
None of the 6 in this group showed 
tissue culture ·growth. 
2 of the 6 in this group showed tissue 
culture growth,which was delcyed (being 
evident at 10 dcys)and which ceased after 
a. further 10 days. 
Healthy control canine valves showed the usual prompt growth 
within 4 - 5 days, indicating that the poor growth was not 
ascribable to technique. 
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5) Assessment of origin of cells grown in tissue culture 
The other half of the leaflet removed under sterile conditions 
from the opened conduits was set up independantly in tissue culture 
as described in Section 6b 'Assessment of origin of cells grown in 
tissue culture'. Similar difficulties were experienced in growing 
the tissues of the long-term valves, and this did not appear to be 
a technical difficulty as control healthy canine valves grew promptly, 
as did control tissue in the independant study described in the 
preceding paragraph. 
As a result of the poor yield of healthy fibroblasts in 
tissue culture it was possible only to identify chromosomes in two 
animals - both with 'viable' valves. 
One animal ('Dumas') - a male recipient with a female donor 
valve - showed only 2 cells with clearly identifiable chromosomes; 
here Y chromosomes were clearly identifiable, showing the male 
origin of those cells - i.e. their host origin. 
The second animal ('Pearl') - a female recipient with a 
male donor valve showed 28 cells with clearly identifiable 
chromosomes; here Y chromosomes were clearly identifiable in al:L, 
showing the male origin of those cells - i.e. their donor origin. 




6) Assessment of Protein and Collagen Synthesis by the 
Implanted Allograft Valve 
~'he methods described in Section 5a for the assessment of 
Protein and Collagen Synthesis were applied to one leaflet of 
each of the removed 'long- term ' valves. 
The results are shown below; those showing tissue culture 
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IN VIVO S'l1tJDY OF POST-IMPLANTATION VIABILITY OF HEART VALVE LEAFLETS 
'11he results r eported in Section 6c indicate:-
At time of valve insertion: 
i) Allograft pulmonary valve-bearing conduits could 
be implanted in the right ventricular outflow of 
dogs with a relatively low operative mortality 
(2 deaths in 30 operations). 
ii) Normal physiological function of the allograft 
valves was shown after implantation in all cases. 
iii) The state of viability of the allograft valves was 
accurately defined by established criteria (Section 
5a), dependant solely on the duration of prior 
storage in Antibiotic-nutrient solution. 
At time of valve removal: 
i) Allograft valves which were 'viable' at insertion showed -
a • . After one week of implantation - normal valve function; 
slight thickening of valve leaflets; and increas8d 
leaflet cellularity due to an inflammatory reaction. 
( 6 valves). 
b. After 4 weeks of implantation - normal valve function; 
further leaflet thickening; inflammatory cellular 
reaction , but areas of focal necrosis in the leaflets. 
(2 valves). 
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c. After 8 weeks of implantation - 7 of the 8 valves 
showed total loss of function, due to gross shrinkage 
and retraction of leaflets. There was virtually 
complete loss of leafl et cellularity - 3 of the 8 
showed small focal areas of cellularity. 
ii) Allo graft valves which were 'non-viable' at insert ion showed -
a. After one week of implantation - normal valve function; 
leaflets devoid of cells; no inflanunatory reaction. 
(6 valves). 
b. After 8 weeks of implantation - normal function retained; 
leaflets not shrunken; devoid of cells.(6 valves). 
iii) Allograft valve viability was lost during 8 weeks of 
implantation. 
E.'vidence for this loss of viability was:-
a. The progression from normal cellularity at time of 
implantation, to an inflammatory reaction after one 
week of implantation, with evidence of focal necrosis 
at 4 weeks, and finally I virtually total acell ulari ty 
at 8 weeks. 
b. Sluggish tissue culture growth in only 6 of 8 valves 
at 8 weeks, which ceased in 4, and was active enough 
in only 2 to allow chromosome identification. 
c. Demonstration of protein synthetic activity in only 
3 of 8 valves at 8 weeks, and absence of collagen 
synthetic activity in all 8. 
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DISCUSSION 
The guestion of whether fibroblast viability is maintained following 
isotopic allotransplantation of a viable valve: 
The animal model used in this study was chosen to simulate 
as closely as possible the clinical situation of allograft valve 
implantation. 
The potential pitfalls inherent in making assumptions 
regarding human clinical behaviour from results of animal experi-
ments are well recognised. However, such assumptions have been 
made in this field, and this has been the justification for the 
assumption that allograft leaflet viability is maintained after 
implantation (Section 2). 
Tne conflicting experimental findi.ings of various groups, 
reviewed in Section 3a, range from the finding of rapid loss of 
cellularity in viable leaflets within 3 weeks of implantation 
(Duran et al., 1965; Duran and Whitehead, 1966; Beall et al., 1961) 
to the findings of prolonged donor cell survival and increased 
leaflet cellulari ty for at least 6 months (Mohri et al., 1967a, ---
1967b, 1968b; Buch et al. , 1971; Kosek et al. , 1969). 
This experimental study has clearly shown rapid loss of 
leaflet cellularity in 'viable' valves by 8 weeks. 
An indication of a possible explanation for the conflicting 
experimental findings in the past is raised by the presence of 
focal areas of incr eased cellularity in certain s ect ions . Thes e 
were small foci, seen in 3 of the 8 long-term ' viable' l eaflets. 
In the cont ext of the early hypercellularity with i nflamm atory 
response at 1 week; going on to virtually total lo s s of cellul ari ty 
by 8 weeks, thes e foci cannot be seen as evidence t hat viability 
is r etained, but r at her than t hey are t he l ast r emaining areas of 
viability in otherwis e dead l eafl et ti ssue . 
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It is not clearly established from this study whether these 
areas are of host or donor origin. However, a donor origin appears 
the more likely in view of the fact that the cellular areas are 
bon.centrated within the original l eaflet tissue (as defined by the 
elastic stain); and they are not continuous with any cellular areas 
toward the base of the leafl et and host tissue. In fact, the 
conduit .;has chosen with deliberate physical separation of host and 
donor tissue in mind, in an attempt to clarify just such a problem. 
Also, these cellular areas were not seen in the non-viable leaflets. 
These cellular areas fit the descriptions and illustrations 
of the cellular leaflets described following implantation of viable 
valves by Mohri et al. (1967 a , 1967b and 1968 ), Buch et al. (1971) 
and Kosek· et al. (1 969 ). 
The allograft valve has been implanted experimentally in 
various ways. In this study, as in the studies of Duran et al. 
(19 65 ) and Beall et al. (1 961 ), the valve was implanted as part 
of a conduit, necessitating implantation of a relatively large 
amount of donor tissue. In the studies of Mohri et al. ( 1967a 
and 1967b), Buch et al. (1 97 1) and Kosek et al. (1 969) the allograft 
leaflet s were implanted either singly, or on a frame, which 
involved smaller quantities of donor tissue. 
It has been shown by Heslop et al. (1973) that the myo.cardial 
component of the allograft valve is the main site of antigenicity. 
The aortic wall is only marginally antigenic , and the l eaflets 
are apparently not antigenic. Thus, differing experL~ents , 
using differing methods of leaflet implantation with varying 
runounts of the components of the valve-complex, could well 
provoke differing immune r esponses - allowing varying donor 
l eaflet fibroblast survival. 
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valves implanted for 8 weeks. Protein synthetic activity (at a 
low level) could be demonstrated in one of these. This 
illustrat ed the difficulties of assessment of post-implantation 
viability, and indicates the possible room for doubt about claims 
of viability in leaflets removed after implantation (Al-Janabi , 
1975a). 
Clearly, some donor cells at least, are still '• surviving at 
8 weeks, as evidence by identification of chromosomes of donor 
sex in cells growing in tissue culture from a viable valve 
implanted for 8 weeks. The use of chromosome identification 
to allow determination of origin was preferred to the use of 
sex chromatin (Barr body) identification. The incidence of 
Barr bodies varies in different tissues, and :.increases as cells 
become more crowded and their nucJei. become smaller. Older 
cells are more likely to contain Barr bodies than younger ones . 
In rapidly dividing tissues, the incidence of Barr bodies is 
lower than in cells in which mitoses have become rare (Mittwoch, 
1973). The decrease in Barr-body-positive cell percentage has 
caused difficulty in interpretation in this field previously 
(Mohri et al_., 1968b ; Gavin, 1973a). 
The identification of chromosomes was possible only in 
two valves - this was due to difficulty in obtaining sufficently 
active tissue culture growth from the r ecovered leaflet explants. 
It is thus considered to be a reflection of much impaired viability 
of the implanted valves. 
It must be remembered that the histological sections were 
made through t he middle of one leaflet of each valve. Between 
10 and 20 sections , each 5 microns thick, were cut for each valve, 
which itself measured between 10 and 20 millimetres wide (see 
Figure 6b-1 1 and Figure 6c- 29 ). 'I'hus, the histological picture 
is of only a small sample of each valve . 
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Even where retained viability has been shown for 
relatively long times after implantation, it is clear that 
leaflet cellularity decreased considerably by 11 to 12 months 
(Mohri et al. , 1968b ). 
That an immune respons e is elicited by the allograft valve 
in the intra-cardiac position, has been demonstrated by many 
workers (Buch et al., 1971; Kosek et al., 1969 ; Baue et al., 
1968; Lower et al., 1960; Teeter et al., 1971). The 
inflanunatory response demonstrated in all 6 'viable' · valves at 
one week of implantation in this study was shown not to be due 
to infection and was not present in any of the 6 'non-viable' 
controls. r.rhe histological features were compatible with 
acute rejection and resembled the changes seen in acutely 
rejected canine and human cardiac allografts (Roitt, 1972; 
Pappas et al., 1967; Hudson, 1975). Loss of leaflet endothelium, 
which has been calledthe hallmark of visceral allograft rejection, 
was also seen (Kosek et al., 1969). 
By the criteria for viability used in the in vitro canine 
study (Section 5a) the evidence for retained viability in the 
8-weeks-implanted viable leaflets was very poor: 
6 of the 8 valves in this group showed tissue culture 
growth, but it was sluggish or transient growth, being 
suffiQ:i.ently active in only two cases to allow identi-
fication of chromosomes in the cells - and in one of 
these a donor origin was establi shed. 
Protein synthetic activity was absent in 5 of the 8 
valves, and collagen synthetic activity could not be 
demonstrated in any of the 8. 
It is of i nterest to note that tissue culture growth 
(sluggi sh and transient) could be shown in 2 of the 6 ' non-viable' 
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While there is no r eason to expect that this is not a 
representative sample, it is clearly the explanation of apparently 
cell-free leaflets showing tissue culture growth or protein 
synthetic activity, as both these investigations were made on 
one entire leaflet each. 
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The question of whether, in antibiotic sterilised valves, the state 
of fibroblast viability can be shown to influence valve structure 
and function followin g isotopic allotransplantation: 
In this animal model it was shown iii.at . pre-implantation 
viability, far from being advantageous, resulted in gross distortion 
of the valve leaflets with consequent loss of function. Non-viable 
valves, in striking contrast, showed minimal alteration of basic 
leaflet architecture, with retention of normal function. 
It would appear from this study, that the acute rejection 
process evoked by the viable valve, causes severe structural 
damage to the valve leaflets. 
Al though other workers have suggested that viable valves 
may not be as good as non-viable valves in- terms of long-term 
structural state(Duran and Whitehead , 1966; Mohri et al., 1968b; 
Suzuki et al. , 1970) the differences have not been as strikingly 
shown as in this study, and there has not been a report of a 
comparison between viable and non-viable antibiotic sterilised 
valves such as this one. 
The suggestion by Angell et al., ( 1973a) that the thickening 
seen in the viable valves following implantation is advantageous, 
is not supported by the appearance of the few foci of cellularity 
in this study, which were associated. with gross distortion. 
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SUMMARY 
The animal study has shown that under the condit iom chosen 
to simulate clinical allograft valve implantation, fibroblast 
viability in viable antibiotic sterilised valve leaflets is not 
maintained f ollowing implantation. 
Furthermore I gross leaflet distortion and consequent loss 
of fu.~ction is seen in the viable antibiotic-sterilised leaflets ; 
by contrast, non-viable antibiotic sterilised leaflets retain 
structure and function and behave in the manner of clinical 
allograft leaflets at this stage of implantation . 
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IN VITRO STUDY OF TISSUE CUL'I'URE, PRO'I'EIN A:~ID COLLAGEN SYN'I'HESIS IN 
ANTIBIOTIC S'I'.ERILISE,1) CANINE HEART VALVES 
'11his s t udy , reported in Section 5a , has shown that leaflet 
fibroblast viability could be reliably retained for at least one 
week of storage in Antibiotic-nutrient so l ution , but after 3 weeks 
of storage it is rarel y present , and by 4 weeks of storage it i s 
absent . 
These valves were obtained under optimal conditions fo r t he 
maintenance of viability . Such conditions could not be approached 
in human work . This study therefore casts considerable doubt on 
viability in human heart val ves used in clinical practice . 
IN VITRO S'rUDY OF VIABILITY IN HUMAN HEART VALVES 
PREPARED FOR GRAFTING 
T'nis study , reported in Section 5b , has shown that human 
valves obtained from-routine autopsy sources are rarely viable . 
This confirms the doubts raised by the canine study ( Section 5a). 
SUMMARY 
'rhus , i n combination , Section 5 and 6 clearly indicate that 
the efforts to maintain leaflet fibroblast viability in heart valve 
leaflets in clinical practice are unnecessary , as are the tests for 
v iability that have been advocated .• 
It is clear that virtually all allograft huJnan valves used 
followi ng antibiotic sterilisation and storage by the method 
described for clinical use , have been non-viable valves . Indeed, 
the striving for improved vi ability may be hazardous, as implantation 
of a viable valve in the human may well result in the changes seen 
in the in vivo canine study with viable valves . 
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Review of the literature suggests that very few, if any 
of the valves used in clinical practice were in fact viable. 
The valves used o.riginally by Murray et al. ( 1956) had been 
stored in electrolyte solution, and as shown by Reichenbach et al. 
(1971) such viability is rapidly lost. This also applies to the 
valves inserted by Barratt-Boyes between 1962 and 1964 1 and the 
report by Gavin et al. (1 973a ) supports this view. Gavin et al. 
(1973c) clearly believe that donor valve viability is not retained 
prior to implantation, using their formula for antibiotic 
sterilisation. They also believe that cellularity of antibiotic 
sterilised valves is lost by 40 days after implantation (Gavin, 1973b). 
The findings of this study, therefore, should contribute 
considerably to answering the questions raised in Section 2 
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